{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:06:54Z","timestamp":1794726414760,"version":"4.9.1"},"reference-count":367,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006250","name":"Southwest University","doi-asserted-by":"crossref","award":["SWU Grant 5330500183"],"award-info":[{"award-number":["SWU Grant 5330500183"]}],"id":[{"id":"10.13039\/501100006250","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11011-021-00800-w","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T21:02:56Z","timestamp":1635714176000},"page":"67-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment"],"prefix":"10.1007","volume":"37","author":[{"given":"Nishit","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Vimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishi","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Hongyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-7188","authenticated-orcid":false,"given":"Sanjib","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"800_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","volume":"161","author":"N Abolhassani","year":"2017","unstructured":"Abolhassani N, Leon J, ShengZ OS, HamasakiH IT, Nakabeppu Y (2017) Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain. Mech Ageing Dev 161:95\u2013104. https:\/\/doi.org\/10.1016\/j.mad.2016.05.005","journal-title":"Mech Ageing Dev"},{"key":"800_CR2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-014-7331-x","volume":"261","author":"A Abraham","year":"2014","unstructured":"Abraham A, Drory VE (2014) Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: A meta-analysis. J Neurol 261:1133\u20131138","journal-title":"J Neurol"},{"issue":"1","key":"800_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0546-4","volume":"12","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh S, Steinacker P, Polischi B, Mammana A, Bartoletti-Stella A, Oeckl P, Baiardi S, Zenesini C, Huss A, Cortelli P, Capellari S (2020) CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia. Alzheimer\u2019s research & therapy 12(1):1\u201315","journal-title":"Alzheimer\u2019s research & therapy"},{"issue":"15","key":"800_CR4","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/bioinformatics\/btv173","volume":"31","author":"S Agarwal","year":"2015","unstructured":"Agarwal S, Ghanty P, Pal NR (2015) Identification of a small set of plasma signalling proteins using neural network for prediction of Alzheimer's disease. Bionformatics 31(15):2505\u20132513","journal-title":"Bionformatics"},{"issue":"6","key":"800_CR5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.mibio.2003.09.010","volume":"5","author":"ED Agdeppa","year":"2003","unstructured":"Agdeppa ED, Kepe V, Liu J, Small GW, Huang SC, Petri\u010d A, Satyamurthy N, Barrio JR (2003) 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Molecular Imaging & Biology 5(6):404\u2013417","journal-title":"Molecular Imaging & Biology"},{"key":"800_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-16-1","volume":"16","author":"SSSJ Ahmed","year":"2009","unstructured":"Ahmed SSSJ, Santosh W, Kumar S, Christlet HTT (2009) Metabolic profiling of Parkinson\u2019s disease: Evidence of bio- marker from gene expression analysis and rapid neural network detection. J Biomed Sci 16:1\u201312","journal-title":"J Biomed Sci"},{"key":"800_CR7","doi-asserted-by":"crossref","unstructured":"Akhtar A, Andleeb A, Waris TS, Bazzar M, Moradi AR, Awan NR, Yar M (2020) Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics. J Controlled Release.","DOI":"10.1016\/j.jconrel.2020.11.021"},{"issue":"5","key":"800_CR8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/S1355617701755105","volume":"7","author":"MS Albert","year":"2001","unstructured":"Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Intl Neuropsychol Soc: JINS 7(5):631","journal-title":"J Intl Neuropsychol Soc: JINS"},{"issue":"4","key":"800_CR9","first-page":"224","volume":"7","author":"M Am","year":"2019","unstructured":"Am M, Manthiannem E, Chethan N, Tousif AH, Ray B, Bhat A, Babu CS (2019) Biomarkers in Neurodegenerative Diseases. EC Pharmacol Toxicol 7(4):224\u2013230","journal-title":"EC Pharmacol Toxicol"},{"issue":"3","key":"800_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","volume":"58","author":"N Andreasen","year":"2001","unstructured":"Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K (2001) Evaluation of CSF-tau and CSF-A\u03b242 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58(3):373\u2013379","journal-title":"Arch Neurol"},{"issue":"4","key":"800_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15622970310029912","volume":"4","author":"N Andreasen","year":"2003","unstructured":"Andreasen N, Sj\u00f6gren M, Blennow K (2003) CSF markers for Alzheimer's disease: total tau, phospho-tau and A\u03b242. World J Biol Psych 4(4):147\u2013155","journal-title":"World J Biol Psych"},{"key":"800_CR12","doi-asserted-by":"crossref","unstructured":"Andreasson U, Portelius E, Andersson ME, Blennow K, Zetterberg H, (2007) Aspects of \u03b2-amyloid as a biomarker for Alzheimer\u2019s disease. 59-78","DOI":"10.2217\/17520363.1.1.59"},{"issue":"11","key":"800_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","volume":"7","author":"PM Andersen","year":"2011","unstructured":"Andersen PM, AlChalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nature Rev Neurol 7(11):603\u2013615","journal-title":"Nature Rev Neurol"},{"key":"800_CR14","first-page":"98","volume":"3","author":"U Andreasson","year":"2016","unstructured":"Andreasson U, Blennow K, Zetterberg H (2016) Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 3:98\u2013102","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"800_CR15","doi-asserted-by":"publisher","unstructured":"Annanmaki T, Muuronen A, Murros K (2007) Low plasma uric acid level in Parkinson\u2019s disease. Mov Disord. https:\/\/doi.org\/10.1002\/mds.21502","DOI":"10.1002\/mds.21502"},{"issue":"2","key":"800_CR16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.22907","volume":"25","author":"P Auinger","year":"2010","unstructured":"Auinger P, Kieburtz K, Mcdermott MP (2010) The relationship between uric acid levels and Huntington's disease progression. Movement Disorders 25(2):224\u2013228","journal-title":"Movement Disorders"},{"key":"800_CR17","doi-asserted-by":"publisher","unstructured":"Ayano G, (2016) Dopamine: Receptors, Functions, Synthesis, Pathways, Locations and Mental Disorders: Review of Literatures. J Ment Disord Treat. https:\/\/doi.org\/10.4172\/2471-271x.1000120","DOI":"10.4172\/2471-271x.1000120"},{"key":"800_CR18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fneur.2015.00236","volume":"6","author":"AL Baird","year":"2015","unstructured":"Baird AL, Westwood S, Lovestone S (2015) Blood-based proteomic biomarkers of Alzheimer's disease pathology. Front Neurol 6:236","journal-title":"Front Neurol"},{"issue":"7","key":"800_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14737159.2019.1627202","volume":"19","author":"F Baldacci","year":"2019","unstructured":"Baldacci F, Lista S, Vergallo A, Palermo G, Giorgi FS, Hampel H (2019) A frontline defense against neurodegenerative diseases: the development of early disease detection methods. Expert Rev Mol Diag 19(7):559\u2013563","journal-title":"Expert Rev Mol Diag"},{"issue":"3","key":"800_CR20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","volume":"26","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TL, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC (2020) A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease. Nature Med 26(3):398\u2013407","journal-title":"Nature Med"},{"issue":"4","key":"800_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phrs.2003.11.018","volume":"50","author":"L Bertram","year":"2004","unstructured":"Bertram L, Tanzi RE (2004) The current status of Alzheimer\u2019s disease genetics: what do we tell the patients? Pharmacol Res 50(4):385\u2013396","journal-title":"Pharmacol Res"},{"issue":"11","key":"800_CR22","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1523\/JNEUROSCI.23-11-04560.2003","volume":"23","author":"O Berezovska","year":"2003","unstructured":"Berezovska O, Ramdya P, Skoch J, Wolfe MS, Bacskai BJ, Hyman BT (2003) Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1\u2013\u03b3-secretase complex in cells demonstrated by fluorescence lifetime imaging. J Neurosci 23(11):4560\u20134566","journal-title":"J Neurosci"},{"issue":"10","key":"800_CR23","doi-asserted-by":"crossref","first-page":"1700108","DOI":"10.1002\/adbi.201700108","volume":"1","author":"S Bhattacharyya","year":"2017","unstructured":"Bhattacharyya S, Kim K, Teizer W (2017a) Remodelling Tau and Prion Proteins Using Nanochaperon. Adv Biosyst 1(10):1700108","journal-title":"Adv Biosyst"},{"issue":"3","key":"800_CR24","doi-asserted-by":"crossref","first-page":"1600034","DOI":"10.1002\/adbi.201600034","volume":"1","author":"S Bhattacharyya","year":"2017","unstructured":"Bhattacharyya S, Kim K, Teizer W (2017b) Restoring the Processivity of Kinesin Nanomotors. Adv Biosyst 1(3):1600034","journal-title":"Adv Biosyst"},{"issue":"12","key":"800_CR25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1039\/C6IB00182C","volume":"8","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Kim K, Nakazawa H, Umetsu M, Teizer W (2016) Modulating the microtubule\u2013tau interactions in bio-motility systems by altering the chemical environment. Integrative Biol 8(12):1296\u20131300","journal-title":"Integrative Biol"},{"issue":"7","key":"800_CR26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/awh176","volume":"127","author":"B Bielekova","year":"2004","unstructured":"Bielekova B, Martin R (2004) Development of biomarkers in multiple sclerosis. Brain 127(7):1463\u20131478","journal-title":"Brain"},{"issue":"6","key":"800_CR27","first-page":"832","volume":"54","author":"G Binetti","year":"2003","unstructured":"Binetti G, Signorini S, Squitti R, Alberici A, Benussi L, Cassetta E, Battista Frisoni G, Barbiero L, Feudatari E, Nicosia F, Testa C (2003) Atypical dementia associated with a novel presenilin-2 mutation. Annals Neurol Official J Am Neurol Assoc Child Neurol Soc 54(6):832\u2013836","journal-title":"Annals Neurol Official J Am Neurol Assoc Child Neurol Soc"},{"key":"800_CR28","doi-asserted-by":"crossref","unstructured":"Bittner S, Afzali AM, Wiendl H, Meuth SG (2014) Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice. J Visual Exp JoVE 86","DOI":"10.3791\/51275"},{"issue":"3","key":"800_CR29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2011-110566","volume":"27","author":"M Bjerke","year":"2011","unstructured":"Bjerke M, Zetterberg H, Edman \u00c5, Blennow K, Wallin A, Andreasson U (2011) Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease. J Alzheimer\u2019s Disease 27(3):665\u2013676","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"10","key":"800_CR30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","volume":"15","author":"M Bj\u00f6rkqvist","year":"2006","unstructured":"Bj\u00f6rkqvist M, Peters\u00e9n \u00c5, Bacos K, Isaacs J, Norlen P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P (2006) Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington's disease. Human Mol Gen 15(10):1713\u20131721","journal-title":"Human Mol Gen"},{"issue":"1","key":"800_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029868","volume":"7","author":"M Bjorkqvist","year":"2012","unstructured":"Bjorkqvist M, Ohlsson M, Minthon L, Hansson O (2012) Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease. PLoS One. 7(1):e29868","journal-title":"PLoS One."},{"key":"800_CR32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ene.12851","volume":"23","author":"H Blasco","year":"2015","unstructured":"Blasco H, Nadal-Desbarats L, Pradat PF, Gordon PH, Madji Hounoum B, Patin F, Veyrat-Durebex C, Mavel S, Beltran S, Emond P, Andres CR (2015) Bio- markers in amyotrophic lateral sclerosis: Combining meta- bolomic and clinical parameters to define disease progression. Eur J Neurol 23:346\u2013353","journal-title":"Eur J Neurol"},{"issue":"4","key":"800_CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","volume":"81","author":"K Blennow","year":"1990","unstructured":"Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L (1990) Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurologica Scandinavica 81(4):323\u2013326","journal-title":"Acta Neurologica Scandinavica"},{"issue":"6","key":"800_CR34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000106963","volume":"6","author":"K Blennow","year":"1995","unstructured":"Blennow K, Davidsson P, Wallin A, Ekman R (1995a) Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer\u2019s disease? Dementia and Geriatric Cognitive Disorders 6(6):306\u2013311","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"3","key":"800_CR35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, \u00c5gren H, Spenger C, Siegfried J, Vanmechelen E (1995b) Tau protein in cerebrospinal fluid. Mol Chem Neuropathol 26(3):231\u2013245","journal-title":"Mol Chem Neuropathol"},{"issue":"10","key":"800_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer's disease. Lancet Neurol 2(10):605\u2013613","journal-title":"Lancet Neurol"},{"issue":"3","key":"800_CR37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0361-9230(03)00086-8","volume":"61","author":"K Blennow","year":"2003","unstructured":"Blennow K, Vanmechelen E (2003) CSF markers for pathogenic processes in Alzheimer\u2019s disease: diagnostic implications and use in clinical neurochemistry. Brain Res Bull 61(3):235\u2013242","journal-title":"Brain Res Bull"},{"issue":"6","key":"800_CR38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer's disease: current status and prospects for the future. J Internal Med 284(6):643\u2013663","journal-title":"J Internal Med"},{"issue":"5","key":"800_CR39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000216841","volume":"27","author":"ES Blom","year":"2009","unstructured":"Blom ES, Giedraitis V, Zetterberg H, Fukumoto H, Blennow K, Hyman BT, Irizarry MC, Wahlund LO, Lannfelt L, Ingelsson M (2009) Rapid progression from mild cognitive impairment to Alzheimer\u2019s disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE \u03b54\/\u03b54 genotype. Dementia and Geriatric Cognitive Disorders 27(5):458\u2013464","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"800_CR40","doi-asserted-by":"crossref","unstructured":"Bloom GS. (2014). Amyloid-b and tau the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71,505\u2013508.","DOI":"10.1001\/jamaneurol.2013.5847"},{"key":"800_CR41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.irbm.2012.08.002","volume":"33","author":"EP Botosoa","year":"2012","unstructured":"Botosoa EP, Zhu M, Marbeuf-Gueye C, Triba MN, Dutheil F, Duyck\u00e4erts C, Beaune P, Loriot MA, Le Moyec L (2012) NMR metabolomic of frontal cortex extracts: first study comparing two neurodegenerative diseases, Alzheimer disease and amyotrophic lateral sclerosis. IRBM 33:281\u2013286","journal-title":"IRBM"},{"key":"800_CR42","doi-asserted-by":"publisher","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, B\u00f6ckmann A, Meier BH, Melki R (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4. https:\/\/doi.org\/10.1038\/ncomms3575","DOI":"10.1038\/ncomms3575"},{"issue":"6","key":"800_CR43","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2016.09.015","volume":"13","author":"WD Brenowitz","year":"2017","unstructured":"Brenowitz WD, Hubbard RA, Keene CD, Hawes SE, Longstreth WT Jr, Woltjer RL, Kukull WA (2017) Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimer's & Dementia 13(6):654\u2013662. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.015","journal-title":"Alzheimer's & Dementia"},{"key":"800_CR44","doi-asserted-by":"publisher","unstructured":"Bridel C, Van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFL Group; Cerme\u00f1o JCA, Andreasson U, Axelsson M , B\u00e4ckstr\u00f6m DC , Bartos A , Bjerke M, Blennow K, Boxer A, Brundin L, Burman J , Christensen T , Fialov\u00e1 L , Forsgren L, Frederiksen JL, Gissl\u00e9n M, Gray E , Gunnarsson M, H Sara, Hansson O, Herbert MK, Jakobsson J , Krut JJ , Janelidze S , Johannsson G , Jonsson M , Kappos L, Khademi M , Khalil M , Kuhle J , Land\u00e9n M , Leinonen V , Logroscino G , Lu CH , Lycke J , Magdalinou NK , Malaspina A , Mattsson N , Meeter LH , Mehta SR , Modvig S , Olsson T , Paterson RW , Santiago JP , Piehl FY, Pijnenburg YAL, Pyykk\u00f6 OT, Ragnarsson O, Rojas JC, Christensen JR, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillb\u00e4ck T, Stilund M, Sundstr\u00f6m P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, Swieten JCV, V\u00e5gberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkels\u00f8 C, Wild EJ (2019) Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534","DOI":"10.1001\/jamaneurol.2019.1534"},{"key":"800_CR45","doi-asserted-by":"crossref","unstructured":"Britschgi M, Rufibach K, Huang SL, Clark CM, Kaye JA, Li G, Peskind ER, Quinn JF, Galasko DR, Wyss-Coray T, (2011) Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol Cell Proteomics, 10(10):M111 008862","DOI":"10.1074\/mcp.M111.008862"},{"issue":"3","key":"800_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jalz.2011.12.006","volume":"9","author":"JN Browndyke","year":"2013","unstructured":"Browndyke JN, Giovanello K, Petrella J, Hayden K, Chiba-Falek O, Tucker KA, Burke JR, Welsh-Bohmer KA (2013) Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease. Alzheimer\u2019s & Dementia 9(3):284\u2013294","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"8","key":"800_CR47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneur.59.8.1267","volume":"59","author":"K Buerger","year":"2002","unstructured":"Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C (2002) Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 59(8):1267\u20131272","journal-title":"Arch Neurol"},{"issue":"11","key":"800_CR48","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","volume":"129","author":"K Buerger","year":"2006","unstructured":"Buerger K, Ewers M, Pirttil\u00e4 T, Zinkowski R, Alafuzoff I, Teipel SJ, DeBernardis J, Kerkman D, McCulloch C, Soininen H, Hampel H (2006) CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129(11):3035\u20133041","journal-title":"Brain"},{"issue":"1","key":"800_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3530001","volume":"353","author":"RD BURGOYNE","year":"2001","unstructured":"BURGOYNE RD, WEISS JL (2001) The neuronal calcium sensor family of Ca2+-binding proteins. Biochemical Journal 353(1):1\u201312","journal-title":"Biochemical Journal"},{"key":"800_CR50","doi-asserted-by":"publisher","unstructured":"Burre J, Sharma M, Tsetsenis T, Buchman V, Mark Etherton M, and Thomas C. S\u00fcdhof TC, (2010) \u03b1 -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro. Science (80) 329:1663\u20131667. https:\/\/doi.org\/10.1126\/science.1195227","DOI":"10.1126\/science.1195227"},{"issue":"2","key":"800_CR51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0197-4580(02)00084-2","volume":"24","author":"GF Busatto","year":"2003","unstructured":"Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, Buchpiguel CA, Furuie S, Bottino CM (2003) A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer\u2019s disease. Neurobiol Aging 24(2):221\u2013231","journal-title":"Neurobiol Aging"},{"key":"800_CR52","doi-asserted-by":"crossref","unstructured":"Calderon-Garcidue\u00f1as, A.L.; Duyckaerts, C. Chapter 23-Alzheimer disease. In Handbook of Clinical Neurology; Kovacs, G.G., Alafuzoff, I., Eds.; Elsevier: Amsterdam, The Netherlands, 2017; Volume 145, pp. 325\u2013337.","DOI":"10.1016\/B978-0-12-802395-2.00023-7"},{"issue":"4","key":"800_CR53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/awv017","volume":"138","author":"E Canto","year":"2015","unstructured":"Canto E, Tintore M, Villar LM, Costa C, Nurtdinov R, Alvarez-Cermeno JC, Arrambide G, Reverter F, Deisenhammer F, Hegen H, Khademi M (2015) Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. Brain 138(4):918\u2013931","journal-title":"Brain"},{"issue":"7","key":"800_CR54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/jnnp.74.7.968","volume":"74","author":"M Caramins","year":"2003","unstructured":"Caramins M, Halliday G, McCusker E, Trent RJ (2003) Genetically confirmed clinical Huntington\u2019s disease with no observable cell loss. J Neurol Neurosurg Psych 74(7):968\u2013970","journal-title":"J Neurol Neurosurg Psych"},{"issue":"7","key":"800_CR55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","volume":"12","author":"R Casanova","year":"2016","unstructured":"Casanova R, Varma S, Simpson B, Kim M, An Y, Saldana S, Riveros C, Moscato P, Griswold M, Sonntag D, Wahrheit J (2016) Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals. Alzheimer\u2019s & Dementia 12(7):815\u2013822","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"800_CR56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/0271678X15606721","volume":"36","author":"J Castillo","year":"2016","unstructured":"Castillo J, Loza MI, Mirelman D, Brea J, Blanco M, Sobrino T, Campos F (2016) A novel mechanism of neuroprotection: Blood glutamate grabber. J Cereb Blood Flow Metab 36:292\u2013301","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"800_CR57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exger.2009.09.008","volume":"45","author":"A Cedazo-Minguez","year":"2010","unstructured":"Cedazo-Minguez A, Winblad B (2010) Biomarkers for Alzheimer\u2019s disease and other forms of dementia: clinical needs, limitations and future aspects. Exp Gerontol 45(1):5\u201314","journal-title":"Exp Gerontol"},{"key":"800_CR58","doi-asserted-by":"publisher","unstructured":"Chandra S, Fornai F, Kwon H-B, Yazdani U, Atasoy D, Liu X, Hammer RE, Battaglia G, German DC, Castillo PE, Sudhof TC (2004) Double-knockout mice for \u03b1 - and \u00df -synucleins: Effect on synaptic functions. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.0406283101","DOI":"10.1073\/pnas.0406283101"},{"issue":"5","key":"800_CR59","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s12035-015-9264-5","volume":"53","author":"XL Chang","year":"2016","unstructured":"Chang XL, Tan MS, Tan L, Yu JT (2016) The role of TDP-43 in Alzheimer\u2019s disease. Mol Neurobiol 53(5):3349\u20133359","journal-title":"Mol Neurobiol"},{"issue":"3","key":"800_CR60","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-150948","volume":"50","author":"P Chatterjee","year":"2016","unstructured":"Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T (2016) Plasma phospholipid and sphingolipid alterations in presenilin1 mutation carriers: A pilot study. J Alzheimer\u2019s disease 50(3):887\u2013894","journal-title":"J Alzheimer\u2019s disease"},{"issue":"1","key":"800_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-1","volume":"8","author":"S Chen","year":"2013","unstructured":"Chen S, Sayana P, Zhang X, LeW (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegen 8(1):1\u201315","journal-title":"Mol Neurodegen"},{"issue":"10","key":"800_CR62","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"L Cheng","year":"2015","unstructured":"Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF (2015) Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry. 20(10):1188\u20131196","journal-title":"Mol Psychiatry."},{"issue":"2","key":"800_CR63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chi\u00f2","year":"2013","unstructured":"Chi\u00f2 A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41(2):118\u2013130","journal-title":"Neuroepidemiology"},{"key":"800_CR64","doi-asserted-by":"publisher","unstructured":"Chhor V, Le Charpentier T, Lebon S, Or\u00e9 MV, Celador ID, Josserand J, Degos V, Etienne Jacotot E, Hagberg H, S\u00e4vman K, Mallard C, Gressens P, Fleiss B (2013) Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia In vitro. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2013.02.005","DOI":"10.1016\/j.bbi.2013.02.005"},{"issue":"6405","key":"800_CR65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the \u03b2-amyloid precursor protein in familial Alzheimer's disease increases \u03b2-protein production. Nature 360(6405):672\u2013674","journal-title":"Nature"},{"issue":"1","key":"800_CR66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid \u03b2-protein in both transfected cells and transgenic mice. Nature Medicine 3(1):67\u201372","journal-title":"Nature Medicine"},{"issue":"26","key":"800_CR67","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM197612232952604","volume":"295","author":"SR Cohen","year":"1976","unstructured":"Cohen SR, Herndon RM, McKhann GM (1976) Radioimmunoassay of myelin basic protein in spinal fluid: an index of active demyelination. New England J Med 295(26):1455\u20131457","journal-title":"New England J Med"},{"key":"800_CR68","doi-asserted-by":"crossref","unstructured":"Cohen AD, Landau SM, Snitz BE, Klunk WE, Blennow K, Zetterberg H. Fluid and PET biomarkers for amyloid pathology in Alzheimer\u2019s disease. Mol Cell Neurosci. 2019;97:3\u201317.","DOI":"10.1016\/j.mcn.2018.12.004"},{"issue":"2","key":"800_CR69","first-page":"120","volume":"7","author":"VC Constantinides","year":"2020","unstructured":"Constantinides VC, Paraskevas GP, Boufidou F, Bourbouli M, Paraskevas PG, Stefanis L, Kapaki E (2020) Cerebrospinal fluid amyloid beta and tau proteins in atypical Parkinsonism: a review. Neuroimmunol Neuroinflamm 7(2):120\u2013131","journal-title":"Neuroimmunol Neuroinflamm"},{"issue":"3","key":"800_CR70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/15622975.2017.1369566","volume":"20","author":"AC Costa","year":"2019","unstructured":"Costa AC, Joaquim HP, Forlenza O, Talib LL, Gattaz WF (2019) Plasma lipids metabolism in mild cognitive impairment and Alzheimer\u2019s disease. World J Biol Psych 20(3):190\u2013196","journal-title":"World J Biol Psych"},{"key":"800_CR71","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/NEN.0000000000000116","volume":"73","author":"Y Cui","year":"2014","unstructured":"Cui Y, Liu X, Wang M, Liu L, Sun X, Ma L, Xie W, Wang C, Tang S, Wang D, Wu Q (2014) Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics. J Neuropathol Exp Neurol 73:954\u2013963","journal-title":"J Neuropathol Exp Neurol"},{"key":"800_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1\u2013105","journal-title":"Prog Neurobiol"},{"issue":"2","key":"800_CR73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/mp.2014.139","volume":"20","author":"J Davis","year":"2015","unstructured":"Davis J, Maes M, Andreazza A, McGrath JJ, Tye SJ, Berk M (2015) Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass. Mol. Psychiatry 20(2):152\u2013153. https:\/\/doi.org\/10.1038\/mp.2014.139","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"800_CR74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cyto.b.20031","volume":"63","author":"BH Davis","year":"2005","unstructured":"Davis BH, Zarev PV (2005) Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytom Part B: Clin Cytom J Intl Soc Anal Cytol 63(1):16\u201322","journal-title":"Cytom Part B: Clin Cytom J Intl Soc Anal Cytol"},{"issue":"2","key":"800_CR75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02815094","volume":"27","author":"P Davidsson","year":"1996","unstructured":"Davidsson P, Jahn R, Bergquist J, Ekman R, Blennow K (1996) Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid. Mol Chem Neuropathol 27(2):195\u2013210","journal-title":"Mol Chem Neuropathol"},{"issue":"3","key":"800_CR76","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/(SICI)1522-2683(19990301)20:3<431::AID-ELPS431>3.0.CO;2-2","volume":"20","author":"P Davidsson","year":"1999","unstructured":"Davidsson P, Puchades M, Blennow K (1999) Identification of synaptic vesicle, pre-and postsynaptic proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing. Electrophoresis: Intl J 20(3):431\u2013437","journal-title":"Electrophoresis: Intl J"},{"issue":"3","key":"800_CR77","first-page":"553","volume":"4","author":"MJ de Leon","year":"1983","unstructured":"de Leon MJ, George AE, Ferris SH, Rosenbloom S, Christman DR, Gentes CI, Reisberg B, Kricheff II, Wolf AP (1983) Regional correlation of PET and CT in senile dementia of the Alzheimer type. Am J Neuroradiol 4(3):553\u2013556","journal-title":"Am J Neuroradiol"},{"issue":"4","key":"800_CR78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/jpm10040221","volume":"10","author":"E Del Prete","year":"2020","unstructured":"Del Prete E, Beatino MF, Campese N, Giampietri L, Siciliano G, Ceravolo R, Baldacci F (2020) Fluid candidate biomarkers for Alzheimer\u2019s Disease: A precision medicine approach. J Personal Med 10(4):221","journal-title":"J Personal Med"},{"key":"800_CR79","doi-asserted-by":"crossref","unstructured":"Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury C.M, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B, (2009) Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain, 132(8):2048-2057.","DOI":"10.1093\/brain\/awp123"},{"issue":"2","key":"800_CR80","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/bj20030240","volume":"374","author":"RR Desrosiers","year":"2003","unstructured":"Desrosiers RR, Bertrand Y, Nguyen QT, Demeule M, Gabathuler R, Kennard ML, Gauthier S, B\u00e9liveau R (2003) Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease. Biochem J 374(2):463\u2013471","journal-title":"Biochem J"},{"key":"800_CR81","doi-asserted-by":"publisher","unstructured":"Di Maio R, Hoffman EK, Rocha EM, Keeney MT, Sanders LH, Briana R, De Miranda BRD, Zharikov A, Laar AV, Stepan AF, Lanz TA, Kofler JK, Burton EA, Alessi DR, Hastings TG, Greenamyre JT (2018) LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aar5429","DOI":"10.1126\/scitranslmed.aar5429"},{"key":"800_CR82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"800_CR83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00003495-200363030-00004","volume":"63","author":"M Dib","year":"2003","unstructured":"Dib M (2003) Amyotrophic Lateral Sclerosis. Drugs 63(3):289\u2013310","journal-title":"Drugs"},{"issue":"2","key":"800_CR84","first-page":"126","volume":"87","author":"G Disanto","year":"2016","unstructured":"Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, Evdoshenko E, Thouvenot E, Trojano M, Norgren N, Teunissen C (2016) Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. J Neurol Neurosurg Psych 87(2):126\u2013129","journal-title":"J Neurol Neurosurg Psych"},{"issue":"10","key":"800_CR85","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69(10):1318\u20131325","journal-title":"Arch Neurol"},{"issue":"2","key":"800_CR86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.22055","volume":"68","author":"H Dolan","year":"2010","unstructured":"Dolan H, Crain B, Troncoso J, Resnick SM, Zonderman AB, Obrien RJ (2010) Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol 68(2):231\u2013240","journal-title":"Ann Neurol"},{"key":"800_CR87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"G Downing","year":"2001","unstructured":"Downing G (2001) Biomarkers definitions working group. Biomarkers and surrogate endpoints. Clin Pharmacol Ther 69:89\u201395. https:\/\/doi.org\/10.1067\/mcp.2001.113989","journal-title":"Clin Pharmacol Ther"},{"issue":"21","key":"800_CR88","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.3390\/ijms21218335","volume":"21","author":"M Dulewicz","year":"2020","unstructured":"Dulewicz M, Kulczy\u0144ska-Przybik A, Mroczko B (2020) Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis. Intl J Mol Sci 21(21):8335","journal-title":"Intl J Mol Sci"},{"issue":"12","key":"800_CR89","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/6.12.2087","volume":"6","author":"CB Eckman","year":"1997","unstructured":"Eckman CB, Mehta ND, Crook R, Perez-tur J, Prihar G, Pfeiffer E, Graff-Radford N, Hinder P, Yager D, Zenk B, Refolo LM (1997) A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A\u03b242 (43). Human Mol Gen 6(12):2087\u20132089","journal-title":"Human Mol Gen"},{"key":"800_CR90","doi-asserted-by":"publisher","unstructured":"El-Agnaf OMA, Salem SA, Paleologou KE (2006) Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J. https:\/\/doi.org\/10.1096\/fj.03-1449com","DOI":"10.1096\/fj.03-1449com"},{"issue":"6","key":"800_CR91","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0277-9536(94)00138-J","volume":"40","author":"JF Emard","year":"1995","unstructured":"Emard JF, Thouez JP, Gauvreau D (1995) Neurodegenerative diseases and risk factors: a literature review. Social Sci Med 40(6):847\u2013858","journal-title":"Social Sci Med"},{"issue":"9","key":"800_CR92","doi-asserted-by":"crossref","first-page":"e12308","DOI":"10.15252\/emmm.202012308","volume":"12","author":"M Ewers","year":"2020","unstructured":"Ewers M, Biechele G, Su\u00e1rez-Calvet M, Sacher C, Blume T, Morenas-Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G, Shaw L (2020) Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation. EMBO Mol Med 12(9):e12308","journal-title":"EMBO Mol Med"},{"issue":"5","key":"800_CR93","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awn034","volume":"131","author":"M Ewers","year":"2008","unstructured":"Ewers M, Zhong Z, B\u00fcrger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H (2008) Increased CSF-BACE 1 activity is associated with ApoE-\u03b54 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Brain 131(5):1252\u20131258","journal-title":"Brain"},{"issue":"1-2","key":"800_CR94","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jneuroim.2007.04.016","volume":"187","author":"BO Fabriek","year":"2007","unstructured":"Fabriek BO, M\u00f8ller HJ, Vloet RP, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BM, van den Berg TK, Dijkstra CD (2007) Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmun 187(1-2):179\u2013186","journal-title":"J Neuroimmun"},{"issue":"3","key":"800_CR95","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A\u03b242 in humans. Ann Neurol 59(3):512\u2013519","journal-title":"Ann Neurol"},{"issue":"1","key":"800_CR96","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/gps.4695","volume":"33","author":"M Fern\u00e1ndez-Matarrubia","year":"2018","unstructured":"Fern\u00e1ndez-Matarrubia M, Mat\u00edas-Guiu JA, Cabrera-Mart\u00edn MN, Moreno-Ramos T, Valles-Salgado M, Carreras JL, Mat\u00edas-Guiu J (2018) Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease. Intl J Geriatr Psych 33(1):141\u2013150","journal-title":"Intl J Geriatr Psych"},{"key":"800_CR97","doi-asserted-by":"crossref","unstructured":"Ferri CP, Prince M, Brayne C, et al. (2006). Global prevalence of dementia: A Delphi consensus study. Lancet 366,2112\u2013 2117.","DOI":"10.1016\/S0140-6736(05)67889-0"},{"issue":"6","key":"800_CR98","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ (2015a) Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement 11(6):600\u2013607 e601","journal-title":"Alzheimers Dement"},{"key":"800_CR99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fneur.2015.00237","volume":"6","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M (2015b) Plasma 24-metabolite panel predicts preclinical transition to clinical stages of Alzheimer\u2019s disease. Front Neurol 6:237","journal-title":"Front Neurol"},{"issue":"12","key":"800_CR100","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1021\/ac702628q","volume":"80","author":"RN Fichorova","year":"2008","unstructured":"Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, Chen S, Cosentino L, Curtis K, Dezzutti CS, Donoval B, Doncel GF (2008) Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 80(12):4741\u20134751","journal-title":"Anal Chem"},{"issue":"10","key":"800_CR101","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, L\u00e5ngstr\u00f6m B, Nordberg A (2008) PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29(10):1456\u20131465","journal-title":"Neurobiol Aging"},{"issue":"10242","key":"800_CR102","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","volume":"395","author":"J Fortea","year":"2020","unstructured":"Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I, Fern\u00e1ndez S, Altuna M, Pegueroles J, Montal V, Valldeneu S (2020) Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. The Lancet 395(10242):1988\u20131997","journal-title":"The Lancet"},{"issue":"8","key":"800_CR103","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/S0140-6736(20)30689-9","volume":"132","author":"M Fouquet","year":"2009","unstructured":"Fouquet M, Desgranges B, Landeau B, Duchesnay E, M\u00e9zenge F, De La Sayette V, Viader F, Baron JC, Eustache F, Ch\u00e9telat G (2009) Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain 132(8):2058\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(20)30689-9","journal-title":"Brain"},{"key":"800_CR104","doi-asserted-by":"crossref","unstructured":"Franc R, Fern\u00e1ndez-Su\u00e1rez D (2015) Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol.","DOI":"10.1016\/j.pneurobio.2015.05.003"},{"issue":"16","key":"800_CR105","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, Van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Jama 278(16):1349\u20131356","journal-title":"Jama"},{"issue":"6","key":"800_CR106","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02279767","volume":"240","author":"L Fr\u00f6lich","year":"1991","unstructured":"Fr\u00f6lich L, Kornhuber J, Ihl R, Fritze J, Maurer K, Riederer P (1991) Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF\/serum ratios of albumin and IgG. Eur Arch Psych Clin Neurosci 240(6):363\u2013366","journal-title":"Eur Arch Psych Clin Neurosci"},{"key":"800_CR107","doi-asserted-by":"crossref","unstructured":"Gainotti G, Marra C, Villa G, Parlato V, Chiarotti F (1998) Sensitivity and specificity of some neuropsychological markers of Alzheimer disease. Alzheimer Disease and Associated Disorders.","DOI":"10.1097\/00002093-199809000-00006"},{"key":"800_CR108","doi-asserted-by":"publisher","unstructured":"Gmitterova K, Heinemann U, Gawinecka J, Varges D, Ciesielczyk B, Valkovic P, Benetin J, Zerr I (2009) 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases. Neurodegener Dis. https:\/\/doi.org\/10.1159\/000237221","DOI":"10.1159\/000237221"},{"issue":"1","key":"800_CR109","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","volume":"85","author":"EJ Goetzl","year":"2015","unstructured":"Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D (2015) Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85(1):40\u201347","journal-title":"Neurology"},{"key":"800_CR110","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/elps.201400196","volume":"35","author":"R Gonzalez-Dom\u0131nguez","year":"2014","unstructured":"Gonzalez-Dom\u0131nguez R, Garc\u0131a A, Garc\u0131a-Barrera T, Barbas C, Gomez-Ariza JL (2014a) Metabolomic profiling of se- rum in the progression of Alzheimer\u2019s disease by capillary electrophoresis-mass spectrometry. Electrophoresis 35:3321\u20133330","journal-title":"Electrophoresis"},{"key":"800_CR111","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1007\/s00216-014-8102-3","volume":"406","author":"R Gonzalez-Dom\u0131nguez","year":"2014","unstructured":"Gonzalez-Dom\u0131nguez R, Garc\u0131a-Barrera T, Gomez-Ariza JL (2014b) Using direct infusion mass spectrometry for serum metabolomics in Alzheimer\u2019s disease. Anal Bioanal Chem 406:7137\u20137148","journal-title":"Anal Bioanal Chem"},{"key":"800_CR112","doi-asserted-by":"crossref","unstructured":"Greenberg N, Grassano A, Thambisetty M, Lovestone S, Legido-Quigley C, (2009) A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease. Electrophoresis, 30(7)1:235-1239","DOI":"10.1002\/elps.200800589"},{"issue":"1","key":"800_CR113","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-150060","volume":"47","author":"M Groblewska","year":"2015","unstructured":"Groblewska M, Muszy\u0144ski P, Wojtulewska-Supron A, Kulczy\u0144ska-Przybik A, Mroczko B (2015) The role of visinin-like protein-1 in the pathophysiology of Alzheimer\u2019s disease. J Alzheimer's Disease 47(1):17\u201332","journal-title":"J Alzheimer's Disease"},{"key":"800_CR114","volume":"9","author":"A Gr\u00f6ger","year":"2014","unstructured":"Gr\u00f6ger A, Kolb R, Scha\u00f6fer R, Klose U (2014) Dopamine reduction in the substantia nigra of Parkinson\u2019s disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. PLoS One 9:e84081","journal-title":"PLoS One"},{"issue":"1","key":"800_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun 6(1):1\u201310","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"800_CR116","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WAD.0b013e31827b60d2","volume":"27","author":"LH Guo","year":"2013","unstructured":"Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R (2013) Alzheimer's disease neuroimaging I: plasma proteomics for the identification of Alzheimer disease. Alzheimer Dis Assoc Disord 27(4):337\u2013342","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"800_CR117","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2009.10.086","volume":"468","author":"X Guo","year":"2010","unstructured":"Guo X, Wang Z, Li K, Li Z, Qi Z, Jin Z, Yao L, Chen K (2010) Voxel-based assessment of gray and white matter volumes in Alzheimer's disease. Neurosci Lett 468(2):146\u2013150","journal-title":"Neurosci Lett"},{"issue":"5","key":"800_CR118","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archneur.62.5.770","volume":"62","author":"H Hampel","year":"2005","unstructured":"Hampel H, B\u00fcrger K, Pruessner JC, Zinkowski R, DeBernardis J, Kerkman D, Leinsinger G, Evans AC, Davies P, M\u00f6ller HJ, Teipel SJ (2005) Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Archives of neurology 62(5):770\u2013773","journal-title":"Archives of neurology"},{"issue":"11","key":"800_CR119","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H, O\u2019Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Rev Neurol 14(11):639\u2013652","journal-title":"Nature Rev Neurol"},{"issue":"12","key":"800_CR120","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/archneur.60.12.1768","volume":"60","author":"CK Hand","year":"2003","unstructured":"Hand CK, Devon RS, Gros-Louis F, Rochefort D, Khoris J, Meininger V, Bouchard JP, Camu W, Hayden MR, Rouleau GA (2003) Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. Arch Neurol 60(12):1768\u20131771","journal-title":"Arch Neurol"},{"issue":"1","key":"800_CR121","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/337945","volume":"70","author":"CK Hand","year":"2002","unstructured":"Hand CK, Khoris J, Salachas F, Gros-Louis F, Lopes AAS, Mayeux-Portas V, Brown RH Jr, Meininger V, Camu W, Rouleau GA (2002) A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Human Gen 70(1):251\u2013256","journal-title":"Am J Human Gen"},{"issue":"5580","key":"800_CR122","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"5054","key":"800_CR123","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013186","journal-title":"Science"},{"issue":"4","key":"800_CR124","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.10186","volume":"26","author":"PR Heath","year":"2002","unstructured":"Heath PR, Shaw PJ (2002) Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle & Nerve: Official J Am Assoc Electrodiag Med 26(4):438\u2013458","journal-title":"Muscle & Nerve: Official J Am Assoc Electrodiag Med"},{"issue":"1","key":"800_CR125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","volume":"10","author":"K Henriksen","year":"2014","unstructured":"Henriksen K, O\u2019Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, L\u00f6nneborg A, Wyss-Coray T, Soares H, Bazenet C (2014) The future of blood-based biomarkers for Alzheimer's disease. Alzheimer\u2019s & Dementia 10(1):115\u2013131","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"800_CR126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","volume":"297","author":"C Hesse","year":"2001","unstructured":"Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K (2001) Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 297(3):187\u2013190","journal-title":"Neurosci Lett"},{"issue":"8","key":"800_CR127","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/14737159.2013.850033","volume":"13","author":"K H\u00f6glund","year":"2013","unstructured":"H\u00f6glund K, Salter H (2013) Molecular biomarkers of neurodegeneration. Exp Rev Mol Diag 13(8):845\u2013861","journal-title":"Exp Rev Mol Diag"},{"issue":"49","key":"800_CR128","doi-asserted-by":"crossref","first-page":"20954","DOI":"10.1073\/pnas.0906053106","volume":"106","author":"D Holland","year":"2009","unstructured":"Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM (2009) Alzheimer's Disease Neuroimaging Initiative. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci 106(49):20954\u201320959","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"800_CR129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/brain\/awaa373","volume":"144","author":"K Horie","year":"2021","unstructured":"Horie K, Barth\u00e9lemy NR, Sato C, Bateman RJ (2021) CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer\u2019s disease. Brain 144(2):515\u2013527","journal-title":"Brain"},{"key":"800_CR130","doi-asserted-by":"crossref","DOI":"10.1002\/alz.041644","volume":"16","author":"K Horie","year":"2020","unstructured":"Horie K, Barthelemy NR, Sato C, Bateman RJ (2020) Tau microtubule binding region in cerebrospinal fluid as a biomarker to differentiate tau pathology in Alzheimer\u2019s disease: Biomarkers (non-neuroimaging)\/Differential diagnosis. Alzheimer's & Dementia 16:e041644","journal-title":"Alzheimer's & Dementia"},{"issue":"6","key":"800_CR131","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia AY, Masliah E, McConlogue YGQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L (1999) Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc Natl Acad Sci 96(6):3228\u20133233","journal-title":"Proc Natl Acad Sci"},{"key":"800_CR132","doi-asserted-by":"crossref","unstructured":"Housley, W. J., Pitt, D., & Hafler, D. A. (2015). Biomarkers in multiple sclerosis. Clinical immunology, 161(1), 51-58.","DOI":"10.1016\/j.clim.2015.06.015"},{"issue":"9","key":"800_CR133","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","volume":"79","author":"WT Hu","year":"2012","unstructured":"Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM (2012) Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79(9):897\u2013905","journal-title":"Neurology"},{"issue":"1","key":"800_CR134","volume":"6","author":"YC Huang","year":"2011","unstructured":"Huang YC, Wu YR, Tseng MY, Chen YC, Hsieh SY, Chen CM (2011) Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease. PloS one 6(1):e15809","journal-title":"PloS one"},{"issue":"8","key":"800_CR135","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneide M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K (1999) Improved discrimination of AD patients using \u03b2-amyloid (1-42) and tau levels in CSF. Neurology 52(8):1555\u20131555","journal-title":"Neurology"},{"issue":"147","key":"800_CR136","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Trans Med 4(147):147ra111\u2013147ra111","journal-title":"Sci Trans Med"},{"issue":"5","key":"800_CR137","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/brain\/awt029","volume":"136","author":"Y Iguchi","year":"2013","unstructured":"Iguchi Y, Katsuno M, Niwa JI, Takagi S, Ishigaki S, Ikenaka K, Kawai K, Watanabe H, Yamanaka K, Takahashi R, Misawa H (2013) Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 136(5):1371\u20131382","journal-title":"Brain"},{"key":"800_CR138","doi-asserted-by":"crossref","unstructured":"Ingelsson M (2016) Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other lewy body disorders. Front. Neurosci.","DOI":"10.3389\/fnins.2016.00408"},{"issue":"12","key":"800_CR139","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","volume":"90","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT, Lee EB, Wolk DA, Weintraub D, Chen-Plotkin A, Duda JE (2018) CSF tau and \u03b2-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders. Neurology 90(12):e1038\u2013e1046","journal-title":"Neurology"},{"issue":"2","key":"800_CR140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1602\/neurorx.1.2.226","volume":"1","author":"MC Irizarry","year":"2004","unstructured":"Irizarry MC (2004) Biomarkers of Alzheimer disease in plasma. NeuroRx 1(2):226\u2013234","journal-title":"NeuroRx"},{"key":"800_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.08.060","volume":"14","author":"M Jablonski","year":"2015","unstructured":"Jablonski M, Miller DS, Pasinelli P, Trotti D (2015) ABC transporter-driven pharmacoresistance in amyotrophic lateral sclerosis. Brain Res 14:1\u201314","journal-title":"Brain Res"},{"issue":"5","key":"800_CR142","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"CR Jack Jr","year":"2009","unstructured":"Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132(5):1355\u20131365","journal-title":"Brain"},{"issue":"5","key":"800_CR143","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC (2016) A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87(5):539\u2013547","journal-title":"Neurology"},{"issue":"4","key":"800_CR144","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E (2018) NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia 14(4):535\u2013562","journal-title":"Alzheimer's & Dementia"},{"key":"800_CR145","first-page":"2415","volume":"2016","author":"E Jammeh","year":"2016","unstructured":"Jammeh E, Zhao P, Carroll C, Pearson S, Ifeachor E (2016) Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease. Conf Proc IEEE Eng Med Biol Soc 2016:2415\u20132418","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"issue":"1","key":"800_CR146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep26801","volume":"6","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, Van Westen D, Jeromin A, Song L, Hanlon D, Hehir CAT, Baker D, Blennow K (2016) Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease. Scientific Reports 6(1):1\u201311","journal-title":"Scientific Reports"},{"issue":"2","key":"800_CR147","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","volume":"60","author":"JC Janssen","year":"2003","unstructured":"Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J (2003) Early onset familial Alzheimer\u2019s disease: mutation frequency in 31 families. Neurology 60(2):235\u2013239","journal-title":"Neurology"},{"issue":"5-6","key":"800_CR148","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Trans 109(5-6):813\u2013836","journal-title":"J Neural Trans"},{"issue":"3","key":"800_CR149","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14(3):457\u2013487","journal-title":"J Cell Mol Med"},{"issue":"4","key":"800_CR150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034341","volume":"7","author":"D Johnstone","year":"2012","unstructured":"Johnstone D, Milward EA, Berretta R, Moscato P (2012) Alzheimer's disease neuroimaging I: multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset. PLoS One 7(4):e34341","journal-title":"PLoS One"},{"key":"800_CR151","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11306-008-0106-6","volume":"4","author":"NM Jukarainen","year":"2008","unstructured":"Jukarainen NM, Korhone SP, Laakso MP et al (2008) Quantification of 1H NMR spectra of human cerebrospinal fluid: A protocol based on constrained total-line-shape anal- ysis. Metabolomics 4:150\u2013160","journal-title":"Metabolomics"},{"issue":"4","key":"800_CR152","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ymeth.2012.03.023","volume":"56","author":"JH Kang","year":"2012","unstructured":"Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM (2012) Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer\u2019s disease. Methods 56(4):484\u2013493","journal-title":"Methods"},{"issue":"6","key":"800_CR153","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00401-016-1552-2","volume":"131","author":"JH Kang","year":"2016","unstructured":"Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Walig\u00f3rska T (2016) CSF biomarkers associated with disease heterogeneity in early Parkinson\u2019s disease: the Parkinson\u2019s Progression Markers Initiative study. Acta neuropathologica 131(6):935\u2013949","journal-title":"Acta neuropathologica"},{"issue":"5","key":"800_CR154","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","volume":"131","author":"RN Kalaria","year":"2016","unstructured":"Kalaria RN (2016) Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer\u2019s disease. Acta neuropathologica 131(5):659\u2013685","journal-title":"Acta neuropathologica"},{"key":"800_CR155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.55.2.210","volume":"55","author":"K Kantarci","year":"2000","unstructured":"Kantarci K, Jack CR Jr, Xu YC (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer\u2019s disease a 1H MRS study. Neurology 55:210\u2013217","journal-title":"Neurology"},{"issue":"1-2","key":"800_CR156","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(01)00628-1","volume":"191","author":"J Karitzky","year":"2001","unstructured":"Karitzky J, Ludolph AC (2001) Imaging and neurochemical markers for diagnosis and disease progression in ALS. J Neurol Sci 191(1-2):35\u201341","journal-title":"J Neurol Sci"},{"issue":"10","key":"800_CR157","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A (2018) Neurofilaments as biomarkers in neurological disorders. Nature Rev Neurol 14(10):577\u2013589","journal-title":"Nature Rev Neurol"},{"key":"800_CR158","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","volume":"21","author":"TS Kim","year":"2006","unstructured":"Kim TS, Pae CU, Yoon SJ (2006) Decreased plasma antioxidants in patients with Alzheimer\u2019s disease. Int J Geriatr Psych 21:344\u2013348","journal-title":"Int J Geriatr Psych"},{"issue":"1","key":"800_CR159","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0893-133X(00)00230-X","volume":"25","author":"DK Kim","year":"2001","unstructured":"Kim DK, Seo MY, Lim SW, Kim S, Kim JW, Carroll BJ, Kwon T, Kang SS (2001) Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease. Neuropsychopharmacol 25(1):84\u201390","journal-title":"Neuropsychopharmacol"},{"issue":"10","key":"800_CR160","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acsabm.9b00501","volume":"2","author":"K Kim","year":"2019","unstructured":"Kim K, Subramaniyam S, Galaleldeen A, Nakazawa H, Umetsu M, Teizer W, Bhattacharyya S (2019) Nanoparticle Assisted Remodelling of Proteotoxic SOD1 Mutants Alters the Biointerface of the Functional Interaction of Microtubules and Kinesin Motors. ACS Applied Bio Materials 2(10):4121\u20134128","journal-title":"ACS Applied Bio Materials"},{"issue":"11","key":"800_CR161","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2174\/1567205017666201223152612","volume":"17","author":"J Kim","year":"2020","unstructured":"Kim J, Kim YK (2020) Inflammatory Biomarkers in AD: Implications for Diagnosis. Curr Alzheimer Res 17(11):962\u2013971","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"800_CR162","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","volume":"14","author":"M Kivipelto","year":"2018","unstructured":"Kivipelto M, Mangialasche F, Ngandu T (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nature Rev Neurol 14(11):653\u2013666","journal-title":"Nature Rev Neurol"},{"issue":"11","key":"800_CR163","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1038\/35041139","volume":"2","author":"RR Kopito","year":"2000","unstructured":"Kopito RR, Ron D (2000) Conformational disease. Nature Cell Biol 2(11):E207\u2013E209","journal-title":"Nature Cell Biol"},{"issue":"11","key":"800_CR164","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/omi.2016.0106","volume":"20","author":"M Kori","year":"2016","unstructured":"Kori M, Ayd\u0131n B, Unal S, Arga KY, Kazan D (2016) Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Omics: J Integr Biol 20(11):645\u2013661","journal-title":"Omics: J Integr Biol"},{"issue":"6","key":"800_CR165","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/ane.12151","volume":"128","author":"J Kuhle","year":"2013","unstructured":"Kuhle J, Malmestr\u00f6m C, Axelsson M, Plattner K, Yaldizli \u00d6, Derfuss T, Giovannoni G, Kappos L, Lycke J (2013) Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Acta Neurologica Scandinavica 128(6):e33\u2013e36","journal-title":"Acta Neurologica Scandinavica"},{"key":"800_CR166","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cca.2010.01.016","volume":"411","author":"A Kumar","year":"2010","unstructured":"Kumar A, Bala L, Kalita J (2010) Metabolomic analysis of serum by H NMR spectroscopy in amyotrophic lateral sclerosis. Clin Chim Acta 411:563\u2013567","journal-title":"Clin Chim Acta"},{"issue":"4","key":"800_CR167","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer's disease: A\u03b2, tau and synaptic dysfunction. Trends Mol Med 11(4):170\u2013176","journal-title":"Trends Mol Med"},{"issue":"7","key":"800_CR168","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ (2011) Alzheimer's Disease Neuroimaging Initiative, Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32(7):1207\u20131218","journal-title":"Neurobiol Aging"},{"issue":"4","key":"800_CR169","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR, An International Huntington's Disease Collaborative Group (2004) A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 65(4):267\u2013277","journal-title":"Clinical Genetics"},{"issue":"2","key":"800_CR170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmg.2003.005033","volume":"41","author":"JC Lambert","year":"2004","unstructured":"Lambert JC, Coyle N, Lendon C (2004) The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer\u2019s disease. J Med Gen 41(2):104\u2013112","journal-title":"J Med Gen"},{"issue":"9","key":"800_CR171","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1017\/S1461145711000459","volume":"14","author":"C Laske","year":"2011","unstructured":"Laske C, Leyhe T, Stransky E, Hoffmann N, Fallgatter AJ, Dietzsch J (2011) Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int J Neuropsychopharmacol 14(9):1147\u20131155","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"800_CR172","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpsychires.2006.01.014","volume":"41","author":"C Laske","year":"2007","unstructured":"Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G (2007) BDNF serum and CSF concentrations in Alzheimer\u2019s disease, normal pressure hydrocephalus and healthy controls. J Psych Res 41(5):387\u2013394","journal-title":"J Psych Res"},{"issue":"2","key":"800_CR173","first-page":"122","volume":"30","author":"HY Law","year":"2001","unstructured":"Law HY, Ng ISL, Yoon CS, Zhao Y, Wong MC (2001) Trinucleotide repeat analysis of Huntington's disease gene in Singapore. Ann Acad Med Singapore 30(2):122\u2013127","journal-title":"Ann Acad Med Singapore"},{"key":"800_CR174","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/17482968.2011.619197","volume":"13","author":"KA Lawton","year":"2012","unstructured":"Lawton KA, Cudkowicz ME, Brown MV (2012) Bio- chemical alterations associated with ALS. Amyotroph Lateral Scler 13:110\u2013118","journal-title":"Amyotroph Lateral Scler"},{"key":"800_CR175","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","volume":"42","author":"Y Lee","year":"2019","unstructured":"Lee Y, Lee S, Chang SC, Lee J (2019) Significant roles of neuroinflammation in Parkinson\u2019s disease: therapeutic targets for PD prevention. Arch Pharm Res 42:416\u2013425. https:\/\/doi.org\/10.1007\/s12272-019-01133-0","journal-title":"Arch Pharm Res"},{"issue":"7","key":"800_CR176","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stahler C (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14(7):R78","journal-title":"Genome Biol"},{"key":"800_CR177","unstructured":"Leung K (2011) 2-(1-{6-[(2-[18F] Fluoroethyl)(methyl) amino]-2-naphthyl} ethylidene) malononitrile. ID: NBK23038PMID: 20641245"},{"issue":"2","key":"800_CR178","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","volume":"18","author":"JB Leverenz","year":"2008","unstructured":"Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathology 18(2):220\u2013224","journal-title":"Brain Pathology"},{"issue":"1","key":"800_CR179","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jnen\/60.1.94","volume":"60","author":"E Levy","year":"2001","unstructured":"Levy E, Sastre M, Kumar A, Gallo G, Piccardo P, Ghetti B, Tagliavini F (2001) Codeposition of cystatin C with amyloid-\u03b2 protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 60(1):94\u2013104","journal-title":"J Neuropathol Exp Neurol"},{"key":"800_CR180","doi-asserted-by":"publisher","unstructured":"Lewitt P, Schultz L, Auinger P, Lu M (2011) CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson\u2019s disease. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2011.06.057","DOI":"10.1016\/j.brainres.2011.06.057"},{"issue":"2","key":"800_CR181","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","volume":"8","author":"D Li","year":"2019","unstructured":"Li D, Mielke MM (2019) An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform. Neurol Ther 8(2):73\u201382","journal-title":"Neurol Ther"},{"key":"800_CR182","doi-asserted-by":"publisher","unstructured":"Li, Q.X., Berndt, M.C., Bush, A.I., Rumble, B., Mackenzie, I., Friedhuber, A., Beyreuther, K. and Masters, C.L., 1994. Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. 133-142. https:\/\/doi.org\/10.1182\/blood.V84.1.133.133","DOI":"10.1182\/blood.V84.1.133.133"},{"key":"800_CR183","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clinbiochem.2019.05.005","volume":"72","author":"V Lifke","year":"2019","unstructured":"Lifke V, Kollmorgen G, Manuilova E, Oelschlaegel T, Hillringhaus L, Widmann M, von Arnim CA, Otto M, Christenson RH, Powers JL, Shaw LM (2019) Elecsys\u00ae Total-Tau and Phospho-Tau (181P) CSF assays: analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid. Clinical Biochemistry 72:30\u201338","journal-title":"Clinical Biochemistry"},{"key":"800_CR184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","volume":"101-102","author":"S Lista","year":"2013","unstructured":"Lista S, Faltraco F, Prvulovic D, Hampel H (2013) Blood and plasma-based proteomic biomarker research in Alzheimer's disease. Prog Neurobiol 101-102:1\u201317","journal-title":"Prog Neurobiol"},{"key":"800_CR185","doi-asserted-by":"publisher","unstructured":"Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M & Zhang J(2012) DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep. https:\/\/doi.org\/10.1038\/srep00954","DOI":"10.1038\/srep00954"},{"key":"800_CR186","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/cells8070712","volume":"8","author":"J Liu","year":"2019","unstructured":"Liu J, Liu W, Li R, Yang H (2019a) Mitophagy in Parkinson\u2019s Disease: From Pathogenesis to Treatment. Cells 8:712. https:\/\/doi.org\/10.3390\/cells8070712","journal-title":"Cells"},{"issue":"2","key":"800_CR187","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1083\/jcb.201806205","volume":"218","author":"L Liu","year":"2019","unstructured":"Liu L, Ding L, Rovere M, Wolfe MS, Selkoe DJ (2019b) A cellular complex of BACE1 and \u03b3-secretase sequentially generates A\u03b2 from its full-length precursor. J Cell Biol 218(2):644\u2013663","journal-title":"J Cell Biol"},{"key":"800_CR188","doi-asserted-by":"crossref","first-page":"34887","DOI":"10.1074\/jbc.M805682200","volume":"283","author":"X Liu","year":"2008","unstructured":"Liu X, Yamada N, Maruyama W, Osawa T (2008) Formation of dopamine adducts derived from brain polyunsatu- rated fatty acids: Mechanism for Parkinson disease. J Biol Chem 283:34887\u201334895","journal-title":"J Biol Chem"},{"issue":"3","key":"800_CR189","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WAD.0b013e31826d597a","volume":"27","author":"DA Llano","year":"2013","unstructured":"Llano DA, Devanarayan V, Simon AJ (2013) Alzheimer's disease neuroimaging I: evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease. Alzheimer Dis Assoc Disord 27(3):233\u2013243","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"800_CR190","doi-asserted-by":"crossref","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Science translational medicine, 4(147):147ra111-147ra111.","DOI":"10.1126\/scitranslmed.3003748"},{"key":"800_CR191","doi-asserted-by":"publisher","unstructured":"Long J, Pan G, Ifeachor E, Belshaw R (2016) Li X, (2016) Discovery of novel biomarkers for Alzheimer\u2019s disease from blood. Disease markers. https:\/\/doi.org\/10.1155\/2016\/4250480","DOI":"10.1155\/2016\/4250480"},{"key":"800_CR192","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/09687680010028762","volume":"18","author":"B Lopez-Corcuera","year":"2001","unstructured":"Lopez-Corcuera B, Geerlings A, Aragon C (2001) Glycine neurotransmitter transporters: An update. Mol Membr Biol 18:13\u201320","journal-title":"Mol Membr Biol"},{"key":"800_CR193","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/B978-0-12-411462-3.00028-X","volume-title":"Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease","author":"KVQ Luong","year":"2015","unstructured":"Luong KVQ, Nguyen LTH (2015) The role of caffeine in neurodegenerative diseases: possible genetic and cellular signal- ing mechanisms. In: Watson RR, Preedy VR (eds) Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Academic Press, Westminster, pp 261\u2013279"},{"issue":"5","key":"800_CR194","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/156720508785908946","volume":"5","author":"M Mancuso","year":"2008","unstructured":"Mancuso M, Orsucci D, Siciliano G, Murri L (2008) Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? Curr Alzheimer Res 5(5):457\u2013468","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"800_CR195","first-page":"98","volume":"21","author":"NI Mansor","year":"2021","unstructured":"Mansor NI, Ntimi CM, Abdul-Aziz NM, Ling KH, Adam A, Rosli R, Hassan Z, Nordin N (2021) Asymptomatic neurotoxicity of amyloid \u03b2-peptides (A\u03b21-42 and A\u03b225-35) on mouse embryonic stem cell-derived neural cells. Bosnian J Basic Med Sci 21(1):98\u2013110","journal-title":"Bosnian J Basic Med Sci"},{"issue":"4","key":"800_CR196","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","volume":"20","author":"M Mapstone","year":"2014","unstructured":"Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nature Medicine 20(4):415\u2013418","journal-title":"Nature Medicine"},{"issue":"3","key":"800_CR197","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neurobiolaging.2009.03.011","volume":"32","author":"J Marksteiner","year":"2011","unstructured":"Marksteiner J, Kemmler G, Weiss EM, Knaus G, Ullrich C, Mechtcheriakov S, Oberbauer H, Auffinger S, Hinterholzl J, Hinterhuber H et al (2011) Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 32(3):539\u2013540","journal-title":"Neurobiol Aging."},{"issue":"5","key":"800_CR198","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurology 74(5):557\u2013566","journal-title":"JAMA Neurology"},{"issue":"17","key":"800_CR199","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E, Palmqvist S, Baker D, Hehir CAT, Jeromin A, Hanlon D (2016) Plasma tau in Alzheimer disease. Neurology 87(17):1827\u20131835","journal-title":"Neurology"},{"issue":"7000","key":"800_CR200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430(7000):631\u2013639","journal-title":"Nature"},{"issue":"2","key":"800_CR201","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1(2):182\u2013188. https:\/\/doi.org\/10.1602\/neurorx.1.2.182","journal-title":"NeuroRx"},{"issue":"8","key":"800_CR202","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM199802193380804","volume":"338","author":"R Mayeux","year":"1998","unstructured":"Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH (1998) Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. New England J Med 338(8):506\u2013511","journal-title":"New England J Med"},{"issue":"24","key":"800_CR203","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2010.851","volume":"303","author":"FB Mayr","year":"2010","unstructured":"Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC (2010) Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. Jama 303(24):2495\u20132503","journal-title":"Jama"},{"issue":"7","key":"800_CR204","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/hmg\/ddr021","volume":"20","author":"KK McDonald","year":"2011","unstructured":"McDonald KK, Aulas A, Destroismaisons L, Pickles S, Beleac E, Camu W, Rouleau GA, Vande Velde C (2011) TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Human Mol Gen 20(7):1400\u20131410","journal-title":"Human Mol Gen"},{"issue":"1","key":"800_CR205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta PD, Pirttil\u00e4 T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM (2000) Plasma and cerebrospinal fluid levels of amyloid \u03b2 proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57(1):100\u2013105","journal-title":"Arch Neurol"},{"issue":"8","key":"800_CR206","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR Jr (2018) Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau-and amyloid-positron emission tomography. Alzheimer\u2019s & Dementia 14(8):989\u2013997","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"9","key":"800_CR207","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaneurol.2017.1359","volume":"74","author":"MM Mielke","year":"2017","unstructured":"Mielke MM, Hagen CE, Wennberg AM, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Jack CR, Petersen RC, Dage JL (2017) Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the mayo clinic study on aging. JAMA Neurology 74(9):1073\u20131080","journal-title":"JAMA Neurology"},{"issue":"1","key":"800_CR208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","volume":"72","author":"RM Mitchell","year":"2009","unstructured":"Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, Connor JR (2009) A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72(1):14\u201319","journal-title":"Neurology"},{"issue":"4","key":"800_CR209","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2009.05.002","volume":"88","author":"G Modi","year":"2009","unstructured":"Modi G, Pillay V, Choonara YE, Ndesendo VM, du Toit LC, Naidoo D (2009) Nanotechnological applications for the treatment of neurodegenerative disorders. Progress Neurobiol 88(4):272\u2013285","journal-title":"Progress Neurobiol"},{"key":"800_CR210","doi-asserted-by":"publisher","unstructured":"Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner CM et al (2020) Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson\u2019s Disease Progression. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28206","DOI":"10.1002\/mds.28206"},{"issue":"3","key":"800_CR211","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-D\u00f6ring F, Trenkwalder C, Schlossmacher MG (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. The Lancet Neurol 10(3):230\u2013240","journal-title":"The Lancet Neurol"},{"key":"800_CR212","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nicl.2015.08.022","volume":"9","author":"C M\u00f6ller","year":"2015","unstructured":"M\u00f6ller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Pouwels PJ, Barkhof F, Scheltens P (2015) Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study. NeuroImage: Clinical 9:418\u2013429","journal-title":"NeuroImage: Clinical"},{"issue":"3","key":"800_CR213","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.410440322","volume":"44","author":"TJ Montine","year":"1998","unstructured":"Montine TJ, Markesbery WR, Morrow JD, Roberts LJ III (1998) Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Annals Neurology 44(3):410\u2013413","journal-title":"Annals Neurology"},{"key":"800_CR214","doi-asserted-by":"crossref","unstructured":"Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ, (2009) Alzheimer's Disease Neuroimaging Initiative*, Episodic memory loss is related to hippocampal-mediated \u03b2-amyloid deposition in elderly subjects. Brain, 132(5:1310-1323.","DOI":"10.1093\/brain\/awn320"},{"issue":"3","key":"800_CR215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","volume":"49","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nuclear Med 49(3):390\u2013398","journal-title":"J Nuclear Med"},{"key":"800_CR216","doi-asserted-by":"crossref","unstructured":"Motoi Y, Hanger DP, Hasegawa M (2020) Tau Propagation Mechanisms: Cell Models, Animal Models, and Beyond. Front Neurosci, 14.","DOI":"10.3389\/fnins.2020.00456"},{"issue":"4","key":"800_CR217","first-page":"643","volume":"38","author":"N Motter","year":"1995","unstructured":"Motter N, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D (1995) Reduction of \u03b2-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Annals Neurol Official J Am Neurol Assoc Child Neurol Soc 38(4):643\u2013648","journal-title":"Annals Neurol Official J Am Neurol Assoc Child Neurol Soc"},{"key":"800_CR218","doi-asserted-by":"crossref","unstructured":"Multhaup G, Huber O, Bue\u0301e L, and Galas MC. (2015). Amyloid precursor protein (APP) metabolites APP intracellular frag- ment (AICD), Ab42, and Tau in nuclear roles. J Biol Chem 290, 23515\u201323522.l","DOI":"10.1074\/jbc.R115.677211"},{"issue":"3","key":"800_CR219","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1046\/j.1471-4159.2002.01012.x","volume":"82","author":"C M\u00fcnch","year":"2002","unstructured":"M\u00fcnch C, Ebstein M, Seefried U, Zhu B, Stamm S, Landwehrmeyer GB, Ludolph AC, Schwalenst\u00f6cker B, Meyer T (2002) Alternative splicing of the 5\u2032-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J Neurochem 82(3):594\u2013603","journal-title":"J Neurochem"},{"key":"800_CR220","doi-asserted-by":"publisher","unstructured":"Mussap M, Noto A, Cibecchini F, Fanos V (2013) The importance of biomarkers in neonatology. Semin Fetal Neonat M:56\u201364. https:\/\/doi.org\/10.1016\/j.siny.2012.10.006","DOI":"10.1016\/j.siny.2012.10.006"},{"issue":"2","key":"800_CR221","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH (2004) Huntington\u2019s disease genetics. NeuroRx 1(2):255\u2013262","journal-title":"NeuroRx"},{"issue":"7691","key":"800_CR222","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, Fowler C, Li QX, Martins R, Rowe C, Tomita T (2018) High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature 554(7691):249\u2013254","journal-title":"Nature"},{"key":"800_CR223","doi-asserted-by":"crossref","unstructured":"Nabizadeh F, Rostami MR, Ahmadi N (2020) CSF total tau, plasma and CSF p tau 181 associated with structural changes in the early stage of Alzheimer's disease.","DOI":"10.21203\/rs.3.rs-135997\/v1"},{"issue":"1","key":"800_CR224","first-page":"1","volume":"49","author":"E Naganska","year":"2011","unstructured":"Naganska E, Matyja E (2011) Amyotrophic lateral sclerosis\u2013looking for pathogenesis and effective therapy. Folia Neuropathologica 49(1):1\u201313","journal-title":"Folia Neuropathologica"},{"issue":"10","key":"800_CR225","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.18632\/oncotarget.15109","volume":"8","author":"S Nagaraj","year":"2017","unstructured":"Nagaraj S, Laskowska-Kaszub K, Debski KJ, Wojsiat J, Dabrowski M, Gabryelewicz T, Kuznicki J, Wojda U (2017) Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects. Oncotarget 8(10):16122\u201316143","journal-title":"Oncotarget"},{"key":"800_CR226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.arr.2018.10.008","volume":"49","author":"S Nagaraj","year":"2019","unstructured":"Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U (2019) microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev 49:125\u2013143","journal-title":"Ageing Res Rev"},{"key":"800_CR227","doi-asserted-by":"publisher","unstructured":"Nagesh Babu G, Gupta M, Paliwal VK, Singh S, Chatterji T, Roy R (2018) Serum metabolomics study in a group of Parkinson\u2019s disease patients from northern India. Clin Chim Acta. https:\/\/doi.org\/10.1016\/j.cca.2018.02.022","DOI":"10.1016\/j.cca.2018.02.022"},{"issue":"6","key":"800_CR228","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist IT (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142(6):1503\u20131527","journal-title":"Brain"},{"issue":"4","key":"800_CR229","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","volume":"48","author":"S Ng","year":"2007","unstructured":"Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, Smith C (2007) Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. J Nuclear Med 48(4):547\u2013552","journal-title":"J Nuclear Med"},{"issue":"6","key":"800_CR230","first-page":"1","volume":"3","author":"A Nordberg","year":"2011","unstructured":"Nordberg A (2011) Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development. Alzheimer\u2019s Res Ther 3(6):1\u20139","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"800_CR231","doi-asserted-by":"crossref","unstructured":"O'brien JT (2007) Role of imaging techniques in the diagnosis of dementia. The British journal of radiology, 80(special_issue_2):S71-S77.","DOI":"10.1259\/bjr\/33117326"},{"issue":"9","key":"800_CR232","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","volume":"67","author":"SE O'Bryant","year":"2010","unstructured":"O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Waring S, Diaz-Arrastia R (2010) Texas Alzheimer's research C: a serum protein- based algorithm for the detection of Alzheimer disease. Arch Neurol 67(9):1077\u20131081","journal-title":"Arch Neurol"},{"issue":"12","key":"800_CR233","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028092","volume":"6","author":"SE O'Bryant","year":"2011","unstructured":"O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R, Texas Alzheimer\u2019s R (2011) A blood- based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One 6(12):e28092","journal-title":"PLoS One"},{"issue":"4","key":"800_CR234","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-141041","volume":"42","author":"SE O'Bryant","year":"2014","unstructured":"O'Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, Como T, Reisch J, Huebinger RM, Graff-Radford N (2014) Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. J Alzheimers Dis 42(4):1325\u20131335","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"800_CR235","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","volume":"11","author":"SE O'Bryant","year":"2017","unstructured":"O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H (2017a) Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimers Dement 11(5):549\u2013560","journal-title":"Alzheimers Dement"},{"issue":"1","key":"800_CR236","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O'Bryant","year":"2017","unstructured":"O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L (2017b) Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 13(1):45\u201358","journal-title":"Alzheimers Dement"},{"issue":"4","key":"800_CR237","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","volume":"45","author":"J Olazaran","year":"2015","unstructured":"Olazaran J, Gil-de-Gomez L, Rodriguez-Martin A, Valenti-Soler M, Frades-Payo B, Marin-Munoz J, Antunez C, Frank-Garcia A, Acedo-Jimenez C, Morlan-Gracia L (2015) A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease. J Alzheimers Dis 45(4):1157\u20131173","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"800_CR238","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, H\u00f6ltt\u00e4 M, Ros\u00e9n C, Olsson C, Strobel G, Wu E (2016) CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol 15(7):673\u2013684","journal-title":"Lancet Neurol"},{"issue":"1","key":"800_CR239","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","volume":"183","author":"A Olsson","year":"2003","unstructured":"Olsson A, H\u00f6glund K, Sj\u00f6gren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, M\u00f6ller HJ, Hampel H, Davidsson P, Blennow K (2003) Measurement of \u03b1-and \u03b2-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol 183(1):74\u201380","journal-title":"Exp Neurol"},{"issue":"8","key":"800_CR240","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","volume":"13","author":"V Ovod","year":"2017","unstructured":"Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, Sullivan M, Paumier K, Holtzman DM, Morris JC, Benzinger T (2017) Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer\u2019s & Dementia 13(8):841\u2013849","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"12","key":"800_CR241","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","volume":"1","author":"M Ore\u0161i\u010d","year":"2011","unstructured":"Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T, Herukka SK, Sysi-Aho M, Mattila I, Sepp\u00e4nan-Laakso T, Julkunen V, Gopalacharyulu PV, Hallikainen M, Koikkalainen J, Kivipelto M (2011) Metabolome in progression to Alzheimer's disease. Trans Psych 1(12):e57\u2013e57","journal-title":"Trans Psych"},{"key":"800_CR242","doi-asserted-by":"crossref","unstructured":"Ortiz GG, Pacheco-Mois\u00e9s FP, Gonz\u00e1lez-Renovato ED, Figuera L, Mac\u00edas-Islas MA, Mireles-Ram\u00edrez M, Flores-Alvarado LJ, S\u00e1nchez-L\u00f3pez A, Nu\u00f1o-Penilla DG, Vel\u00e1zquez-Brizuela IE, S\u00e1nchez-Luna JP, (2015) Genetic, biochemical and histopathological aspects of familiar Alzheimer's disease. In Alzheimer's Disease-Challenges for the Future. IntechOpen.","DOI":"10.5772\/59809"},{"issue":"9","key":"800_CR243","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1212\/01.wnl.0000242732.06714.0f","volume":"67","author":"M \u00d6st","year":"2006","unstructured":"\u00d6st M, Nylen K, Csajbok L, \u00d6hrfelt AO, Tullberg M, Wikkels\u00f6 C, Nellg\u00e5rd P, Rosengren L, Blennow K, Nellg\u00e5rd B (2006) Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67(9):1600\u20131604","journal-title":"Neurology"},{"issue":"6","key":"800_CR244","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","volume":"61","author":"PE O'Suilleabhain","year":"2004","unstructured":"O'Suilleabhain PE, Sung V, Hernandez C, Lacritz L, Dewey RB Jr, Bottiglieri T, Diaz-Arrastia R (2004) Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Arch Neurol 61(6):865\u2013868","journal-title":"Arch Neurol"},{"issue":"3","key":"800_CR245","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S (1997) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease. Neurosci Lett 225(3):210\u2013212","journal-title":"Neurosci Lett"},{"key":"800_CR246","doi-asserted-by":"crossref","first-page":"101771","DOI":"10.1016\/j.nicl.2019.101771","volume":"22","author":"J Ottoy","year":"2019","unstructured":"Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C, Ribbens A (2019) Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid-and 18F-FDG-PET imaging. NeuroImage: Clinical 22:101771","journal-title":"NeuroImage: Clinical"},{"key":"800_CR247","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fneur.2018.00415","volume":"9","author":"S Paciotti","year":"2018","unstructured":"Paciotti S, Bellomo G, Gatticchi L, Parnetti L (2018) Are we ready for detecting \u03b1-synuclein prone to aggregation in patients? The case of \u201cprotein-misfolding cyclic amplification\u201d and \u201creal-time quaking-induced conversion\u201d as diagnostic tools. Front Neurol 9:415","journal-title":"Front Neurol"},{"key":"800_CR248","doi-asserted-by":"crossref","unstructured":"Paglia G, Stocchero M, Cacciatore S, et al. (2016). Unbiased metabolomic investigation of Alzheimer\u2019s disease brain points to dysregulation of mitochondrial aspartate metabo- lism. J Proteome Res 15, 608\u2013618.","DOI":"10.1021\/acs.jproteome.5b01020"},{"key":"800_CR249","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","volume":"11","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, Eichenlaub U, Dage JL, Chai X, Blennow K, Mattsson N (2019) Cerebrospinal fluid and plasma biomarker trajec- tories with increasing amyloid deposition in Alzheimer\u2019s disease. EMBO Mol. Med 11:e11170","journal-title":"EMBO Mol. Med"},{"key":"800_CR250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbd.2014.04.001","volume":"72","author":"J Pahnke","year":"2014","unstructured":"Pahnke J, Langer O, Krohn M (2014) Alzheimer\u2019s and ABC transporters\u2014new opportunities for diagnostics and treatment. Neurobiol Disease 72:54\u201360","journal-title":"Neurobiol Disease"},{"issue":"6","key":"800_CR251","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/humu.9081","volume":"20","author":"MJ Parton","year":"2002","unstructured":"Parton MJ, Broom W, Andersen PM, Al-Chalabi A, Nigel Leigh P, Powell JF, Shaw CE (2002) D90A SOD1 ALS Consortium, D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Human Mutation 20(6):473\u2013473","journal-title":"Human Mutation"},{"key":"800_CR252","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3389\/fneur.2018.01037","volume":"9","author":"M Pawlitzki","year":"2018","unstructured":"Pawlitzki M, Schreiber S, Bittner D, Kreipe J, Leypoldt F, Rupprecht K, Carare RO, Meuth SG, Vielhaber S, K\u00f6rtv\u00e9lyessy P (2018) CSF neurofilament light chain levels in primary progressive MS: signs of axonal neurodegeneration. Front Neurol 9:1037","journal-title":"Front Neurol"},{"key":"800_CR253","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2015.04.014","volume":"595","author":"M Peng","year":"2015","unstructured":"Peng M, Jia J, Qin W (2015) Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease. Neurosci Lett 595:116\u2013121","journal-title":"Neurosci Lett"},{"issue":"4","key":"800_CR254","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","volume":"24","author":"\u00c5 Peters\u00e9n","year":"2006","unstructured":"Peters\u00e9n \u00c5, Bj\u00f6rkqvist M (2006) Hypothalamic\u2013endocrine aspects in Huntington's disease. Eur J Neurosci 24(4):961\u2013967","journal-title":"Eur J Neurosci"},{"issue":"11","key":"800_CR255","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC (2007) \u03b2-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 130(11):2837\u20132844","journal-title":"Brain"},{"issue":"2","key":"800_CR256","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/14789450.5.2.225","volume":"5","author":"E Portelius","year":"2008","unstructured":"Portelius E, Zetterberg H, Gobom J, Andreasson U, Blennow K (2008) Targeted proteomics in Alzheimer\u2019s disease: focus on amyloid-\u03b2. Exp Rev Proteomics 5(2):225\u2013237","journal-title":"Exp Rev Proteomics"},{"issue":"2","key":"800_CR257","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-160767","volume":"60","author":"SP Poulin","year":"2017","unstructured":"Poulin SP, Bergeron D, Dickerson BC (2017) Risk factors, neuroanatomical correlates, and outcome of neuropsychiatric symptoms in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease 60(2):483\u2013493","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"800_CR258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbrainres.2003.08.022","volume":"122","author":"P Preece","year":"2004","unstructured":"Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, Mudge AW, Jazin E, Cairns NJ (2004) Amyloid precursor protein mRNA levels in Alzheimer's disease brain. Mol Brain Res 122(1):1\u20139","journal-title":"Mol Brain Res"},{"key":"800_CR259","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.jcbfm.9600543","volume":"28","author":"ML Prins","year":"2008","unstructured":"Prins ML (2008) Cerebral metabolic adaptation and ketone me- tabolism after brain injury. J Cereb Blood Flow Metab 28:1\u201316","journal-title":"J Cereb Blood Flow Metab"},{"key":"800_CR260","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","volume":"65","author":"C Procaccini","year":"2016","unstructured":"Procaccini C, Santopaolo M, Faicchia D, Colamatteo A, Formisano L, De Candia P, Galgani M, De Rosa V, Matarese G (2016) Role of metabolism in neurodegenerative disorders. Metabolism 65:1376\u20131390","journal-title":"Metabolism"},{"key":"800_CR261","doi-asserted-by":"crossref","unstructured":"Przedborski S, Vila M, Jackson-Lewis V, (2003) Series Introduction: Neurodegeneration: What is it and where are we?. J Clin Invest, 111(1):3-10.","DOI":"10.1172\/JCI200317522"},{"key":"800_CR262","doi-asserted-by":"crossref","unstructured":"Pyatigorskaya N, Gallea C, Garcia-Lorenzo D, Vidailhet M, and Lehericy S, (2014) A review of the use of magnetic resonance imaging in Parkinson\u2019s disease. Ther. Adv. Neurol. Disord.","DOI":"10.1177\/1756285613511507"},{"issue":"8","key":"800_CR263","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awp105","volume":"132","author":"O Querbes","year":"2009","unstructured":"Querbes O, Aubry F, Pariente J, Lotterie JA, D\u00e9monet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P (2009) Alzheimer's Disease Neuroimaging Initiative, Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 132(8):2036\u20132047","journal-title":"Brain"},{"issue":"1","key":"800_CR264","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2004-6110","volume":"6","author":"JF Quinn","year":"2004","unstructured":"Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ (2004) Suppression of longitudinal increase in CSF F 2-isoprostanes in Alzheimer's disease. J Alzheimer\u2019s Disease 6(1):93\u201397","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"5","key":"800_CR265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.cr.7290235","volume":"14","author":"V Rachakonda","year":"2004","unstructured":"Rachakonda V, Pan TH, Le WD (2004) Biomarkers of neurodegenerative disorders: how good are they? Cell Research 14(5):349\u2013358","journal-title":"Cell Research"},{"issue":"11","key":"800_CR266","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 13(11):1359\u20131362","journal-title":"Nat Med."},{"key":"800_CR267","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich SG, Savitt JM (2019) Parkinson\u2019s Disease. Med Clin North Am 103:337\u2013350. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.014","journal-title":"Med Clin North Am"},{"key":"800_CR268","doi-asserted-by":"crossref","unstructured":"Ren R, Sun Y, Zhao X, Pu X, (2015) Recent advances in biomarkers for Parkinson\u2019s disease focusing on biochemicals, omics and neuroimaging. Clin. Chem. Lab. Med.","DOI":"10.1515\/cclm-2014-0783"},{"key":"800_CR269","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12035-018-1084-y","volume":"56","author":"M Repici","year":"2019","unstructured":"Repici M, Hassanjani M, Maddison DC, Gar\u00e7\u00e3o P, Cimini S, Patel B, Szeg\u00f6 EM, Straatman KR, Lilley KS, Borsello T, Outeiro TF, Panman L, Giorgini F (2019) The Parkinson\u2019s Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration. Mol Neurobiol 56:61\u201377. https:\/\/doi.org\/10.1007\/s12035-018-1084-y","journal-title":"Mol Neurobiol"},{"issue":"1","key":"800_CR270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00006231-200201000-00004","volume":"23","author":"NC Reynolds Jr","year":"2002","unstructured":"Reynolds NC Jr, Hellman RS, Tikofsky RS, Prost RW, Mark LP, Elejalde BR, Lebel R, Hamsher KS, Swanson S, Benezra EE (2002) Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease. Nuclear Med Commun 23(1):13\u201318","journal-title":"Nuclear Med Commun"},{"issue":"3","key":"800_CR271","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, F\u00f6rstl H, Kurz A (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt\u2013Jakob disease from other dementias. Mol Psych 8(3):343\u2013347","journal-title":"Mol Psych"},{"issue":"7","key":"800_CR272","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141(7):2181\u20132193","journal-title":"Brain"},{"issue":"6543","key":"800_CR273","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376(6543):775\u2013778","journal-title":"Nature"},{"issue":"1","key":"800_CR274","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-1","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington's disease: a clinical review. Orphanet J rare diseas 5(1):1\u20138","journal-title":"Orphanet J rare diseas"},{"key":"800_CR275","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/S1353-8020(09)70800-4","volume":"15","author":"CA Ross","year":"2009","unstructured":"Ross CA, Shoulson I (2009) Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics. Parkinsonism & Related Disorders 15:S135\u2013S138","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"800_CR276","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcp.13793","volume":"85","author":"A Rowland","year":"2019","unstructured":"Rowland A, Ruanglertboon W, van Dyk M, Wijayakumara D, Wood LS, Meech R, Mackenzie PI, Rodrigues AD, Marshall JC, Sorich MJ (2019) Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure. British J Clin Pharmacol 85(1):216\u2013226","journal-title":"British J Clin Pharmacol"},{"issue":"2","key":"800_CR277","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00234-003-1034-9","volume":"46","author":"HI Sair","year":"2004","unstructured":"Sair HI, Doraiswamy PM, Petrella JR (2004) In vivo amyloid imaging in Alzheimer\u2019s disease. Neuroradiology 46(2):93\u2013104","journal-title":"Neuroradiology"},{"issue":"6","key":"800_CR278","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","volume":"20","author":"C Saft","year":"2005","unstructured":"Saft C, Zange J, Andrich J, M\u00fcller K, Lindenberg K, Landwehrmeye B, Vorgerd M, Kraus PH, Przuntek H, Sch\u00f6ls L (2005) Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Movement Disorders: Official J Movement Disorder Soc 20(6):674\u2013679","journal-title":"Movement Disorders: Official J Movement Disorder Soc"},{"key":"800_CR279","doi-asserted-by":"publisher","unstructured":"Sako W, Murakami N, Izumi Y, Kaji R (2015) Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson\u2019s disease from atypical parkinsonism: Evidence from a meta-analysis. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2015.03.041","DOI":"10.1016\/j.jns.2015.03.041"},{"key":"800_CR280","doi-asserted-by":"crossref","unstructured":"S\u00e4mg\u00e5rd, K., Zetterberg, H., Blennow, K., Hansson, O., Minthon, L., & Londos, E. (2010). Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity. International Journal of Geriatric Psychiatry: A journal of the psychiatry of late life and allied sciences, 25(4), 403-410.","DOI":"10.1002\/gps.2353"},{"key":"800_CR281","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cca.2012.08.013","volume":"414","author":"M Sathya","year":"2012","unstructured":"Sathya M, Premkumar P, Karthick C, Moorthi P, Jayachandran KS, Anusuyadevi M (2012) BACE1 in Alzheimer's disease. Clinica Chimica Acta 414:171\u2013178","journal-title":"Clinica Chimica Acta"},{"issue":"S1","key":"800_CR282","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1002\/humu.1380110131","volume":"11","author":"S Sato","year":"1998","unstructured":"Sato S, Kamino K, Miki T, Doi A, Ii K, St George-Hyslop PH, Ogihara T, Sakaki Y (1998) Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease. Human Mutation 11(S1):S91\u2013S94","journal-title":"Human Mutation"},{"issue":"1","key":"800_CR283","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","volume":"1","author":"P Scheltens","year":"2002","unstructured":"Scheltens P, Fox N, Barkhof F, De Carli C (2002) Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 1(1):13\u201321","journal-title":"Lancet Neurol"},{"key":"800_CR284","doi-asserted-by":"crossref","unstructured":"Scholl M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zet- terberg H, et al. Biomarkers for tau pathology. Mol Cell Neu- rosci. 2019;97:18\u201333.","DOI":"10.1016\/j.mcn.2018.12.001"},{"issue":"3","key":"800_CR285","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/1522-2594(200103)45:3<513::AID-MRM1067>3.0.CO;2-D","volume":"45","author":"N Schuff","year":"2001","unstructured":"Schuff N, Rooney WD, Miller R, Gelinas DF, Amend DL, Maudsley AA, Weiner MW (2001) Reanalysis of multislice 1H MRSI in amyotrophic lateral sclerosis. Magnetic Resonance Med Official J Intl Soc Magnet Resonance Med 45(3):513\u2013516","journal-title":"Magnetic Resonance Med Official J Intl Soc Magnet Resonance Med"},{"issue":"3","key":"800_CR286","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(99)00929-5","volume":"278","author":"K Sennvik","year":"2000","unstructured":"Sennvik K, Fastbom J, Blomberg M, Wahlund LO, Winblad B, Benedikz E (2000) Levels of \u03b1-and \u03b2-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 278(3):169\u2013172","journal-title":"Neurosci Lett"},{"issue":"1","key":"800_CR287","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","volume":"43","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe DJ, Schenk D (2003) Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Ann Rev Pharmacol Toxicol 43(1):545\u2013584","journal-title":"Ann Rev Pharmacol Toxicol"},{"issue":"3","key":"800_CR288","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3233\/JAD-170531","volume":"62","author":"L Shi","year":"2018","unstructured":"Shi L, Baird AL, Westwood S, Hye A, Dobson R, Thambisetty M, Lovestone S (2018a) A decade of blood biomarkers for Alzheimer's disease research: An evolving field, improving study designs, and the challenge of replication. J Alzheimers Dis 62(3):1181\u20131198","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"800_CR289","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jalz.2018.02.015","volume":"14","author":"M Shi","year":"2018","unstructured":"Shi M, Tang L, Toledo JB, Ginghina C, Wang H, Aro P, Jensen PH, Weintraub D, Chen-Plotkin AS, Irwin DJ, Grossman M (2018b) Cerebrospinal fluid \u03b1-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimer\u2019s & Dementia 14(8):1052\u20131062","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"800_CR290","doi-asserted-by":"publisher","unstructured":"Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J (2016) CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2016.04.003","DOI":"10.1016\/j.jalz.2016.04.003"},{"issue":"2","key":"800_CR291","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nbd.2008.09.004","volume":"35","author":"M Shi","year":"2009","unstructured":"Shi M, Caudle WM, Zhang J (2009) Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Disease 35(2):157\u2013164","journal-title":"Neurobiol Disease"},{"issue":"1","key":"800_CR292","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","volume":"10","author":"K Shoghi-Jadid","year":"2002","unstructured":"Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psych 10(1):24\u201335","journal-title":"Am J Geriatr Psych"},{"issue":"6","key":"800_CR293","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00002281-200311000-00008","volume":"15","author":"EP Simpson","year":"2003","unstructured":"Simpson EP, Yen AA, Appel SH (2003) Oxidative stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opinion Rheumatol 15(6):730\u2013736","journal-title":"Curr Opinion Rheumatol"},{"issue":"1-2","key":"800_CR294","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00121-9","volume":"332","author":"M Sj\u00f6gren","year":"2003","unstructured":"Sj\u00f6gren M, Andreasen N, Blennow K (2003) Advances in the detection of Alzheimer's disease\u2014use of cerebrospinal fluid biomarkers. Clinica Chimica Acta 332(1-2):1\u201310","journal-title":"Clinica Chimica Acta"},{"issue":"6","key":"800_CR295","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.57.6.839","volume":"57","author":"BJ Small","year":"2000","unstructured":"Small BJ, Fratiglioni L, Viitanen M, Winblad B, B\u00e4ckman L (2000) The course of cognitive impairment in preclinical Alzheimer disease: three-and 6-year follow-up of a population-based sample. Arch Neurol 57(6):839\u2013844","journal-title":"Arch Neurol"},{"key":"800_CR296","unstructured":"\u015amigielska-Kumzia J, Sobaniec W, (2007) Brain metabolic profile obtained by proton magnetic resonance spectroscopy HMRS in children with Down syndrome. Advances in Medical Sciences (De Gruyter Open), 52."},{"issue":"6769","key":"800_CR297","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/35000576","volume":"403","author":"MA Smith","year":"2000","unstructured":"Smith MA, Brandt J, Shadmehr R (2000) Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 403(6769):544\u2013549","journal-title":"Nature"},{"key":"800_CR298","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2009.05066.x","volume":"1180","author":"HD Soares","year":"2009","unstructured":"Soares HD, Chen Y, Sabbagh M, Roher A, Schrijvers E, Breteler M (2009) Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels. Ann N Y Acad Sci. 1180:56\u201367","journal-title":"Ann N Y Acad Sci."},{"issue":"2","key":"800_CR299","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","volume":"61","author":"F Song","year":"2009","unstructured":"Song F, Poljak A, Smythe GA, Sachdev P (2009) Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev 61(2):69\u201380","journal-title":"Brain Res Rev"},{"issue":"4791","key":"800_CR300","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","volume":"235","author":"PH St George-Hyslop","year":"1987","unstructured":"St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235(4791):885\u2013890","journal-title":"Science"},{"issue":"8","key":"800_CR301","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaneurol.2019.1071","volume":"76","author":"AM Staffaroni","year":"2019","unstructured":"Staffaroni AM, Kramer AO, Casey M, Kang H, Rojas JC, Orr\u00fa CD, Caughey B, Allen IE, Kramer JH, Rosen HJ, Blennow K (2019) Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease. JAMA Neurology 76(8):969\u2013977","journal-title":"JAMA Neurology"},{"key":"800_CR302","doi-asserted-by":"crossref","unstructured":"Stefanis, L, (2012) \u03b1-Synuclein in Parkinson's disease. Cold Spring Harbor perspectives in medicine, 2(2):a009399.","DOI":"10.1101\/cshperspect.a009399"},{"key":"800_CR303","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcn.2018.10.003","volume":"97","author":"P Steinacker","year":"2019","unstructured":"Steinacker P, Barschke P, Otto M (2019) Biomarkers for diseases with TDP-43 pathology. Mol Cell Neurosci 97:43\u201359","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"800_CR304","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11414-013-9386-3","volume":"42","author":"B Steinfeld","year":"2015","unstructured":"Steinfeld B, Scott J, Vilander G, Marx L, Quirk M, Lindberg J, Koerner K (2015) The role of lean process improvement in implementation of evidence-based practices in behavioral health care. J Behav Health Services Res 42(4):504\u2013518","journal-title":"J Behav Health Services Res"},{"issue":"4","key":"800_CR305","doi-asserted-by":"crossref","first-page":"e0119681","DOI":"10.1371\/journal.pone.0119681","volume":"10","author":"M Stilund","year":"2015","unstructured":"Stilund M, Gjelstrup MC, Petersen T, M\u00f8ller HJ, Rasmussen PV, Christensen T (2015) Biomarkers of inflammation and axonal degeneration\/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF\/serum ratio to a biomarker panel. PloS one 10(4):e0119681","journal-title":"PloS one"},{"issue":"6","key":"800_CR306","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel JA (2010) What are biomarkers? Curr Opin HIV Aids 5(6):463\u2013466. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed177","journal-title":"Curr Opin HIV Aids"},{"issue":"4","key":"800_CR307","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF A\u03b2 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60(4):652\u2013656","journal-title":"Neurology"},{"issue":"16","key":"800_CR308","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","volume":"289","author":"T Sunderland","year":"2003","unstructured":"Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ (2003) Decreased \u03b2-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. Jama 289(16):2094\u20132103","journal-title":"Jama"},{"issue":"1","key":"800_CR309","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJ, Jacobs RE (2019) Vascular dysfunction\u2014the disregarded partner of Alzheimer's disease. Alzheimer\u2019s & Dementia 15(1):158\u2013167","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"800_CR310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22318-5","volume":"8","author":"M Szelechowski","year":"2018","unstructured":"Szelechowski M, Amoedo N, Obre E, L\u00e9ger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Scientific Reports 8(1):1\u201314","journal-title":"Scientific Reports"},{"issue":"3","key":"800_CR311","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-130653","volume":"37","author":"A Takashima","year":"2013","unstructured":"Takashima A (2013) Tauopathies and tau oligomers. J Alzheimer\u2019s Disease 37(3):565\u2013568","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1-2","key":"800_CR312","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2005.09.002","volume":"240","author":"K Tang","year":"2006","unstructured":"Tang K, Hynan LS, Baskin F, Rosenberg RN (2006) Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci 240(1-2):53\u201358","journal-title":"J Neurol Sci"},{"issue":"4","key":"800_CR313","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 120(4):545\u2013555","journal-title":"Cell"},{"issue":"3","key":"800_CR314","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttil\u00e4 T (2009) Cerebrospinal fluid \u03b2-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382\u2013389","journal-title":"Arch Neurol"},{"issue":"1","key":"800_CR315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, Kondo M, Allsop D, Tokuda T (2017) Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol Neurodegen 12(1):1\u201311","journal-title":"Mol Neurodegen"},{"key":"800_CR316","doi-asserted-by":"crossref","unstructured":"Terry, R. L., Ifergan, I., & Miller, S. D. (2014). Experimental autoimmune encephalomyelitis in mice. In Multiple Sclerosis (pp. 145-160). Humana Press, New York, NY.","DOI":"10.1007\/7651_2014_88"},{"key":"800_CR317","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","volume":"114","author":"P Thakur","year":"2017","unstructured":"Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Bj\u00f6rklund A (2017) Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain. Proc Natl Acad Sci 114:E8284\u2013E8293. https:\/\/doi.org\/10.1073\/pnas.1710442114","journal-title":"Proc Natl Acad Sci"},{"key":"800_CR318","doi-asserted-by":"crossref","unstructured":"Thal, L.J., Kantarci, K., Reiman, E.M., Klunk, W.E., Weiner, M.W., Zetterberg, H., Galasko, D., Pratic\u00f2, D., Griffin, S., Schenk, D. and Siemers, E., 2006. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer disease and associated disorders, 20(1), p.6.","DOI":"10.1097\/01.wad.0000191420.61260.a8"},{"issue":"1-4","key":"800_CR319","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000335381","volume":"10","author":"L Thurfjell","year":"2012","unstructured":"Thurfjell L, L\u00f6tj\u00f6nen J, Lundqvist R, Koikkalainen J, Soininen H, Waldemar G, Brooks DJ, Vandenberghe R (2012) Combination of biomarkers: PET [18F] flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. Neurodegen Diseases 10(1-4):246\u2013249","journal-title":"Neurodegen Diseases"},{"key":"800_CR320","doi-asserted-by":"publisher","unstructured":"Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, Shi M, Xie Z, Liu N, Feng T, Zhang J (2019) Erythrocytic \u03b1-Synuclein as a potential biomarker for Parkinson\u2019s disease. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-019-0155-y","DOI":"10.1186\/s40035-019-0155-y"},{"key":"800_CR321","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0208-5216(13)70053-6","volume":"33","author":"B Toczylowska","year":"2013","unstructured":"Toczylowska B, Jamrozik Z, Liebert A, Kwiecinski H (2013) NMR-based metabonomics of cerebrospinal fluid applied to amyotrophic lateral sclerosis. Biocybern Biomed Eng 33:21\u201332","journal-title":"Biocybern Biomed Eng"},{"issue":"9","key":"800_CR322","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2967\/jnumed.109.064360","volume":"50","author":"N Tolboom","year":"2009","unstructured":"Tolboom N, van der Flier WM, Yaqub M, Boellaard R, Verwey NA, Blankenstein MA, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN (2009) Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding. J Nuclear Med 50(9):1464\u20131470","journal-title":"J Nuclear Med"},{"issue":"9","key":"800_CR323","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA, Trojanowski JQ (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain 136(9):2697\u20132706","journal-title":"Brain"},{"issue":"6","key":"800_CR324","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jalz.2011.08.008","volume":"8","author":"JB Toledo","year":"2012","unstructured":"Toledo JB, Toledo E, Weiner MW, Jack CR Jr, Jagust W, Lee VMY, Shaw LM, Trojanowski JQ, Initiative A's DN (2012) Cardiovascular risk factors, cortisol, and amyloid-\u03b2 deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimer\u2019s & Dementia 8(6):483\u2013489","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"800_CR325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3233\/JPD-140389","volume":"4","author":"M Trupp","year":"2014","unstructured":"Trupp M, Jonsson P, Ohrfelt A, Zetterberg H, Obudulu O, Malm L, Wuolikainen A, Linder J, Moritz T, Blennow K, Antti H (2014) Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson\u2019s disease. J Parkinsons Dis 4:549\u2013560","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"800_CR326","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","volume":"1842","author":"E Trushina","year":"2014","unstructured":"Trushina E, Mielke MM (2014) Recent advances in the application of metabolomics to Alzheimer's Disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842(8):1232\u20131239","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"5","key":"800_CR327","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1017\/S1355617706060863","volume":"12","author":"EW Twamley","year":"2006","unstructured":"Twamley EW, Ropacki SAL, Bondi MW (2006) Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Intl Neuropsychol Soc: JINS 12(5):707","journal-title":"J Intl Neuropsychol Soc: JINS"},{"issue":"1","key":"800_CR328","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/301672","volume":"62","author":"C Tysoe","year":"1998","unstructured":"Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, Wilcock G, Rubinsztein DC (1998) A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Human Gen 62(1):70\u201376","journal-title":"Am J Human Gen"},{"issue":"2","key":"800_CR329","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.dadm.2015.04.003","volume":"1","author":"K Uchida","year":"2015","unstructured":"Uchida K, Shan L, Suzuki H, Tabuse Y, Nishimura Y, Hirokawa Y, Mizukami K, Akatsu H, Meno K, Asada T (2015) Amyloid-beta sequester proteins as blood-based biomarkers of cognitive decline. Alzheimers Dement (Amst) 1(2):270\u2013280","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"800_CR330","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","volume":"129","author":"BR Underwood","year":"2006","unstructured":"Underwood BR, Broadhurst D, Dunn WB, Ellis DI, Michell AW, Vacher C, Mosedale DE, Kell DB, Barker RA, Grainger DJ, Rubinsztein DC (2006) Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain 129(4):877\u2013886","journal-title":"Brain"},{"key":"800_CR331","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.2741\/ujiie","volume":"7","author":"M Ujiie","year":"2002","unstructured":"Ujiie M, Dickstein DL, Jefferies WA (2002) p97 as a biomarker for Alzheimer disease. Front Biosci J Virtual Library 7:e42\u2013e47","journal-title":"Front Biosci J Virtual Library"},{"issue":"12","key":"800_CR332","first-page":"1472","volume":"44","author":"H Vanderstichele","year":"2006","unstructured":"Vanderstichele H, De Vreese K, Blennow K, Andreasen N, Sindic C, Ivanoiu A, Hampel H, B\u00fcrger K, Parnetti L, Lanari A, Padovani A (2006) Analytical performance and clinical utility of the INNOTEST\u00ae PHOSPHO-TAU (181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin Chem Lab Med(CCLM) 44(12):1472\u20131480","journal-title":"Clin Chem Lab Med(CCLM)"},{"key":"800_CR333","doi-asserted-by":"crossref","unstructured":"Verberk IM, Slot RE, Verfaillie SC, Heijst H, Prins ND, van Berckel, B.N., Scheltens, P, Teunissen CE, van der Flier WM, (2018) Plasma Amyloid as Prescreener for the Earliest A lzheimer Pathological Changes. Annals Neurol, 84(5):.648-658.","DOI":"10.1002\/ana.25334"},{"issue":"4","key":"800_CR334","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/WNL.45.4.788","volume":"45","author":"C Vigo-Pelfrey","year":"1995","unstructured":"Vigo-Pelfrey C, Seubert PP, Barbour R, Blomquist C, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I, Schenk D (1995) Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 45(4):788\u2013793","journal-title":"Neurology"},{"issue":"3","key":"800_CR335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/jpm10030061","volume":"10","author":"C Villa","year":"2020","unstructured":"Villa C, Lavitrano M, Salvatore E, Combi R (2020) Molecular and Imaging Biomarkers in Alzheimer\u2019s Disease: A Focus on Recent Insights. J Personal Med 10(3):61","journal-title":"J Personal Med"},{"issue":"16","key":"800_CR336","doi-asserted-by":"crossref","first-page":"1906861","DOI":"10.1002\/smll.201906861","volume":"16","author":"SK Vimal","year":"2020","unstructured":"Vimal SK, Zuo H, Wang Z, Wang H, Long Z, Bhattacharyya S (2020) Self-Therapeutic Nanoparticle That Alters Tau Protein and Ameliorates Tauopathy Toward a Functional Nanomedicine to tackle Alzheimer\u2019s. Small 16(16):1906861","journal-title":"Small"},{"issue":"7","key":"800_CR337","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ard.59.7.544","volume":"59","author":"K Vos","year":"2000","unstructured":"Vos K, Steenbakkers P, Miltenburg AMM, Bos E, van Den Heuvel MW, Van Hogezand RA, De Vries RRP, Breedveld FC, Boots AMH (2000) Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Annals Rheumatic Diseases 59(7):544\u2013548","journal-title":"Annals Rheumatic Diseases"},{"issue":"3","key":"800_CR338","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1073\/pnas.1317400111","volume":"111","author":"A Vozza","year":"2014","unstructured":"Vozza A, Parisi G, De Leonardis F, Lasorsa FM, Castegna A, Amorese D, Marmo R, Calcagnile VM, Palmieri L, Ricquier D, Paradies E (2014) UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci 111(3):960\u2013965","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"800_CR339","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0404.1990.tb01562.x","volume":"81","author":"A Wallin","year":"1990","unstructured":"Wallin A, Blennow K, Fredman P, Gottfries CG, Karlsson I, Svennerholm L (1990) Blood brain barrier function in vascular dementia. Acta Neurologica Scandinavica 81(4):318\u2013322","journal-title":"Acta Neurologica Scandinavica"},{"key":"800_CR340","doi-asserted-by":"crossref","unstructured":"Wallin A, Blennow K, Rosengren L, (1999) Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype. Alzheimer disease and associated disorders, 13, S102-5.","DOI":"10.1097\/00002093-199912001-00015"},{"issue":"5","key":"800_CR341","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/pr5000895","volume":"13","author":"G Wang","year":"2014","unstructured":"Wang G, Zhou Y, Huang FJ, Tang HD, Xu XH, Liu JJ, Wang Y, Deng YL, Ren RJ, Xu W, Ma JF (2014) Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment. J Proteome Res 13(5):2649\u20132658","journal-title":"J Proteome Res"},{"issue":"Suppl2","key":"800_CR342","first-page":"S116","volume":"13","author":"PR Wattamwar","year":"2010","unstructured":"Wattamwar PR, Mathuranath PS (2010) An overview of biomarkers in Alzheimer\u2019s disease. Annals Indian Acad Neurol 13(Suppl2):S116","journal-title":"Annals Indian Acad Neurol"},{"issue":"4","key":"800_CR343","doi-asserted-by":"crossref","first-page":"a006171","DOI":"10.1101\/cshperspect.a006171","volume":"2","author":"S Weintraub","year":"2012","unstructured":"Weintraub S, Wicklund AH, Salmon DP (2012) The neuropsychological profile of Alzheimer disease. Cold Spring Harbor Perspectives Med 2(4):a006171","journal-title":"Cold Spring Harbor Perspectives Med"},{"issue":"2","key":"800_CR344","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/10408363.2019.1670613","volume":"57","author":"KE Wesenhagen","year":"2020","unstructured":"Wesenhagen KE, Teunissen CE, Visser PJ, Tijms BM (2020) Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer\u2019s disease: a literature review. Critical Rev in Clin Lab Sci 57(2):86\u201398","journal-title":"Critical Rev in Clin Lab Sci"},{"key":"800_CR345","doi-asserted-by":"publisher","unstructured":"Wen M, Zhou B, Chen YH, Ma ZL, Gou Y, Zhang CL, Yu WF, Jiao L (2017) Serum uric acid levels in patients with Parkinson\u2019s disease: A meta-analysis. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0173731","DOI":"10.1371\/journal.pone.0173731"},{"issue":"21","key":"800_CR346","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","volume":"89","author":"PS Weston","year":"2017","unstructured":"Weston PS, Poole T, Ryan NS, Nair A, Liang Y, Macpherson K, Druyeh R, Malone IB, Ahsan RL, Pemberton H, Klimova J (2017) Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration. Neurology 89(21):2167\u20132175","journal-title":"Neurology"},{"key":"800_CR347","doi-asserted-by":"crossref","unstructured":"Whitwell JL, Petersen RC, Negash S, Weigand SD, Kantarci K, Ivnik R.J, Knopman DS, Boeve BF, Smith GE, Jack CR, (2007) Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol, 64(8):1130-1138.","DOI":"10.1001\/archneur.64.8.1130"},{"issue":"3","key":"800_CR348","first-page":"1247","volume":"179","author":"T Wisniewski","year":"1991","unstructured":"Wisniewski T, Ghiso J, Frangione B (1991) Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. BBRC 179(3):1247\u20131254","journal-title":"BBRC"},{"key":"800_CR349","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017947","volume":"6","author":"A Wuolikainen","year":"2011","unstructured":"Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM (2011) Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC\/TOFMS. PLoS One 6:e17947","journal-title":"PLoS One"},{"key":"800_CR350","doi-asserted-by":"publisher","unstructured":"Yamagishi Y, Saigoh K, Saito Y, Ogawa I, Mitsui Y, Hamada Y, Samukawa M, Suzuki H, Kuwahara M, Hirano M, Noguchi N, Kusunoki S (2018) Diagnosis of Parkinson\u2019s disease and the level of oxidized DJ-1 protein. Neurosci Res. https:\/\/doi.org\/10.1016\/j.neures.2017.06.008","DOI":"10.1016\/j.neures.2017.06.008"},{"issue":"4","key":"800_CR351","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"CC Yang","year":"2018","unstructured":"Yang CC, ChiuMJ CTF, Chang HL, Liu BH, Yang SY (2018) Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimer's Disease 61(4):1323\u20131332","journal-title":"J Alzheimer's Disease"},{"issue":"8","key":"800_CR352","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","volume":"17","author":"A Yilmaz","year":"2017","unstructured":"Yilmaz A, Blennow K, Hagberg L, Nilsson S, Price RW, Schouten J, Spudich S, Underwood J, Zetterberg H, Gissl\u00e9n M (2017) Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Exp Rev Mol Diag 17(8):761\u2013770","journal-title":"Exp Rev Mol Diag"},{"issue":"25","key":"800_CR353","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1523\/JNEUROSCI.1081-12.2012","volume":"32","author":"A Yuan","year":"2012","unstructured":"Yuan A, Sasaki T, Kumar A, Peterhoff CM, Rao MV, Liem RK, Julien JP, Nixon RA (2012) Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons. J Neurosci 32(25):8501\u20138508","journal-title":"J Neurosci"},{"key":"800_CR354","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fncel.2015.00322","volume":"9","author":"JE Yuste","year":"2015","unstructured":"Yuste JE, Tarragon E, Campuzano CM, Ros-Bernal F (2015) Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci 9:322","journal-title":"Front Cell Neurosci"},{"key":"800_CR355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2018.05.039","volume":"484","author":"M Zendjabil","year":"2018","unstructured":"Zendjabil M (2018) Circulating microRNAs as novel biomarkers of Alzheimer's disease. Clin Chim Acta 484:99\u2013104","journal-title":"Clin Chim Acta"},{"issue":"8","key":"800_CR356","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ (2008) Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 65(8):1102\u20131107","journal-title":"Arch Neurol"},{"issue":"12","key":"800_CR357","doi-asserted-by":"crossref","first-page":"e28263","DOI":"10.1371\/journal.pone.0028263","volume":"6","author":"H Zetterberg","year":"2011","unstructured":"Zetterberg H, M\u00f6rtberg E, Song L, Chang L, Provuncher GK, Patel PP, Ferrell E, Fournier DR, Kan CW, Campbell TG, Meyer R (2011) Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid \u03b2 levels in humans. PloS one 6(12):e28263","journal-title":"PloS one"},{"issue":"2","key":"800_CR358","first-page":"1","volume":"5","author":"H Zetterberg","year":"2013","unstructured":"Zetterberg H, Wilson D, Andreasson U, Minthon L, Blennow K, Randall J, Hansson O (2013) Plasma tau levels in Alzheimer's disease. Alzheimer\u2019s Res Ther 5(2):1\u20133","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"800_CR359","doi-asserted-by":"crossref","unstructured":"Zetterberg, H., & Burnham, S. C. (2019). Blood-based molecular biomarkers for Alzheimer\u2019s disease. Molecular brain, 12(1), 1-7.","DOI":"10.1186\/s13041-019-0448-1"},{"key":"800_CR360","doi-asserted-by":"crossref","unstructured":"Zetterberg H, Bendlin BB, (2020) Biomarkers for Alzheimer\u2019s disease\u2014preparing for a new era of disease-modifying therapies. Mol Psych, 1-13.","DOI":"10.1038\/s41380-020-0721-9"},{"key":"800_CR361","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ALN.0b013e31823d7731","volume":"116","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Sinelnikov I, Gruenbaum BF, Gruenbaum SE, Dubilet M, Dubilet E, Leibowitz A, Ohayon S, Regev A, Boyko M, Shapira Y (2012) Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology 116:73\u201383","journal-title":"Anesthesiology"},{"issue":"2","key":"800_CR362","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3233\/JAD-141149","volume":"43","author":"X Zhao","year":"2013","unstructured":"Zhao X, Lejnine S, Spond J, Zhang C, Ramaraj TC, Holder DJ, Dai H, Weiner R, Laterza OF (2013) A candidate plasma protein classifier to identify Alzheimer's disease. J Alzheimers Dis 43(2):549\u2013563","journal-title":"J Alzheimers Dis"},{"key":"800_CR363","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2013.03.007","volume":"541","author":"J Zhang","year":"2013","unstructured":"Zhang J, Jia J, Qin W, Wang S (2013) Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer's disease. Neurosci Lett 541:99\u2013104","journal-title":"Neurosci Lett"},{"issue":"6","key":"800_CR364","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","volume":"64","author":"Z Zhong","year":"2007","unstructured":"Zhong Z, Ewers M, Teipel S, B\u00fcrger K, Wallin A, Blennow K, He P, McAllister C, Hampel H, Shen Y (2007) Levels of \u03b2-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psych 64(6):718\u2013726","journal-title":"Arch Gen Psych"},{"issue":"7","key":"800_CR365","volume":"8","author":"H Zhu","year":"2013","unstructured":"Zhu H, Bogdanov MB, Boyle SH, Matson W, Sharma S, Matson S, Churchill E, Fiehn O, Rush JA, Krishnan RR, Pickering E (2013) Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder\u2013possible role for methoxyindole pathway. PloS one 8(7):e68283","journal-title":"PloS one"},{"issue":"24","key":"800_CR366","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1002\/elps.201200360","volume":"33","author":"P Zurbig","year":"2012","unstructured":"Zurbig P, Jahn H (2012) Use of proteomic methods in the analysis of human body fluids in Alzheimer research. Electrophoresis. 33(24):3617\u20133630","journal-title":"Electrophoresis."},{"key":"800_CR367","doi-asserted-by":"publisher","unstructured":"Author (1995) Cerebrospinal fluid homovanillic acid in the datatop study on parkinson\u2019s disease. Arch Neurol. https:\/\/doi.org\/10.1001\/archneur.1995.00540270025015","DOI":"10.1001\/archneur.1995.00540270025015"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00800-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-021-00800-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00800-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T20:21:20Z","timestamp":1699734080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-021-00800-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":367,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s11011-021-00800-w","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Manuscript complies with ethical standard","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. (Not Applicable)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not Applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Not Applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"There were no human participants or animals used in this study. (Not Applicable)","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Authors declare no conflict of interest for this review article","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}}]}}